0001171843-16-011397.txt : 20160801 0001171843-16-011397.hdr.sgml : 20160801 20160801164200 ACCESSION NUMBER: 0001171843-16-011397 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160801 DATE AS OF CHANGE: 20160801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 161797822 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 10-Q 1 f10q_080116p.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2016

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 000-21326

Anika Therapeutics, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Massachusetts	04-3145961
(State or Other Jurisdiction of	(I.R.S. Employer Identification No.)
Incorporation or Organization)

32 Wiggins Avenue, Bedford, Massachusetts	01730
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code: (781) 457-9000

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report: N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐

Accelerated filer ☒

Non-accelerated filer ☐

(Do not check if a smaller

reporting company)

Smaller reporting

company ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes ☐ No ☒

As of July 28, 2016 there were 14,777,663 outstanding shares of Common Stock, par value $.01 per share.

ANIKA THERAPEUTICS, INC.

TABLE OF CONTENTS

		Page

Part I	Financial Information
Item 1.	Financial Statements (unaudited):	3
	Condensed Consolidated Balance Sheets as of June 30, 2016 and December 31, 2015	3
	Condensed Consolidated Statements of Operations and Comprehensive Income for the three and six months ended June 30, 2016 and 2015	4
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2016 and 2015	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	18
Part II	Other Information
Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Mine Safety Disclosures	20
Item 6.	Exhibits	20
Signatures		21

References in this Quarterly Report on Form 10-Q to “we,” “us,” “our,” “our company,” and other similar references refer to Anika Therapeutics, Inc. and its subsidiaries unless the context otherwise indicates.

ANIKA, ANIKA THERAPEUTICS, CINGAL, HYAFF, MONOVISC, and ORTHOVISC are our registered trademarks. This Quarterly Report on Form 10-Q also contains registered marks, trademarks, and trade names that are the property of other companies and licensed to us.

PART I: FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Anika Therapeutics, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands, except share data and per share data)

(unaudited)

	June 30,			December 31,
ASSETS	2016			2015
Current assets:
Cash and cash equivalents	$	89,125		$	110,707
Investments		22,500			27,751
Accounts receivable, net of reserves of $220 and $167 at June 30, 2016 and December 31, 2015, respectively		24,597			21,652
Inventories		17,264			14,938
Prepaid expenses and other current assets		1,158			1,385
Total current assets		154,644			176,433
Property and equipment, net		49,198			40,108
Long-term deposits and other		69			69
Intangible assets, net		11,259			11,656
Goodwill		7,568			7,482
Total Assets	$	222,738		$	235,748

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	3,294		$	8,302
Accrued expenses and other current liabilities		6,638			4,778
Income taxes payable		591			4,198
Total current liabilities		10,523			17,278
Other long-term liabilities		1,173			781
Long-term deferred revenue		56			66
Deferred tax liability		6,570			6,775
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively		-			-
Common stock, $.01 par value; 60,000,000 and 30,000,000 shares authorized, 14,777,663 and 15,036,808 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively		148			150
Additional paid-in-capital		59,506			81,685
Accumulated other comprehensive loss		(6,410	)		(6,649	)
Retained earnings		151,172			135,662
Total stockholders’ equity		204,416			210,848
Total Liabilities and Stockholders’ Equity	$	222,738		$	235,748

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Anika Therapeutics, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income

(in thousands, except per share data)

(unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016		2015
Product revenue	$	26,575		$	22,898		$	48,853	$	38,413
Licensing, milestone and contract revenue		6			6			11		11
Total revenue		26,581			22,904			48,864		38,424

Operating expenses:
Cost of product revenue		6,065			5,275			11,490		9,588
Research & development		2,792			1,812			4,951		3,910
Selling, general & administrative		4,255			3,388			8,245		6,993
Total operating expenses		13,112			10,475			24,686		20,491
Income from operations		13,469			12,429			24,178		17,933
Interest income, net		49			24			121		48
Income before income taxes		13,518			12,453			24,299		17,981
Provision for income taxes		4,903			4,634			8,789		6,646
Net income	$	8,615		$	7,819		$	15,510	$	11,335

Basic net income per share:
Net income	$	0.59		$	0.52		$	1.05	$	0.76
Basic weighted average common shares outstanding		14,679			14,961			14,778		14,934
Diluted net income per share:
Net income	$	0.57		$	0.51		$	1.02	$	0.74
Diluted weighted average common shares outstanding		15,111			15,336			15,210		15,332

Net income	$	8,615		$	7,819		$	15,510	$	11,335
Other comprehensive income (loss):
Unrealized gain (loss) on securities, net of tax		-			(3	)		-		(3	)
Foreign currency translation adjustment		(536	)		420			238		(1,828	)
Total other comprehensive income (loss)		(536	)		417			238		(1,831	)
Comprehensive income	$	8,079		$	8,236		$	15,748	$	9,504

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Anika Therapeutics, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Six Months Ended June 30,
	2016			2015
Cash flows from operating activities:
Net income	$	15,510		$	11,335
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		1,901			1,827
Stock-based compensation expense		1,478			1,064
Deferred income taxes		(252	)		(428	)
Provision for doubtful accounts		52			-
Provision for inventory		181			68
Tax benefit from equity awards		(419	)		(934	)
Changes in operating assets and liabilities:
Accounts receivable		(2,932	)		(2,389	)
Inventories		(2,438	)		496
Prepaid expenses, other current and long-term assets		186			459
Accounts payable		(4,252	)		559
Accrued expenses and other current liabilities		446			(264	)
Deferred revenue		(45	)		(5	)
Income taxes payable		(3,169	)		3,194
Other long-term liabilities		396			(98	)
Net cash provided by operating activities		6,643			14,884

Cash flows from investing activities:
Proceeds from maturity of investments		27,750			10,250
Purchase of investments		(22,499	)		(22,018	)
Purchase of property and equipment		(9,869	)		(1,134	)
Net cash used in investing activities		(4,618	)		(12,902	)

Cash flows from financing activities:
Repurchases of common stock		(25,000	)		-
Proceeds from exercise of equity awards		922			969
Tax benefit from equity awards		419			934
Net cash (used in) provided by financing activities		(23,659	)		1,903

Exchange rate impact on cash		52			(121	)

Increase (decrease) in cash and cash equivalents		(21,582	)		3,764
Cash and cash equivalents at beginning of period		110,707			100,156
Cash and cash equivalents at end of period	$	89,125		$	103,920
Supplemental disclosure of cash flow information:
Non-cash Investing Activities:
Purchases of property and equipment included in accounts payable and accrued expenses	$	2,128		$	116

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ANIKA THERAPEUTICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(amounts in thousands, except per share amounts or as otherwise noted)

(unaudited)

Nature of Business

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions by providing innovative and differentiated therapeutic pain management solutions along the continuum of care, from palliative care to regenerative medicine. The Company has over two decades of expertise developing, manufacturing, and commercializing more than 20 products, in markets across the globe, based on the Company’s proprietary hyaluronic acid technology. The Company’s orthopedic medicine portfolio is comprised of marketed (ORTHOVISC and MONOVISC) and pipeline (CINGAL and HYALOFAST in the United States, among others) products to alleviate pain and restore joint function by replenishing depleted HA and aiding cartilage repair and regeneration.

The Company is subject to risks common to companies in the biotechnology and medical device industries including, but not limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, commercialization of existing and new products, and compliance with U.S. Food and Drug Administration (“FDA”) and foreign regulations and approval requirements, as well as the ability to grow the Company’s business through appropriate commercial strategies.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and related notes have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and in accordance with accounting principles generally accepted in the United States (“US GAAP”). The financial statements include the accounts of Anika Therapeutics, Inc. and its subsidiaries. Inter-company transactions and balances have been eliminated. The year-end consolidated balance sheet is derived from the Company’s audited financial statements, but does not include all disclosures required by US GAAP. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to fairly state the condensed consolidated financial position of the Company as of June 30, 2016, the results of its operations for the three- and six-month periods ended June 30, 2016 and 2015, and cash flows for the six-month periods ended June 30, 2016 and 2015.

The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s annual financial statements filed with its Annual Report on Form 10-K for the year ended December 31, 2015. The results of operations for the three- and six-month periods ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016. Certain prior period amounts have been reclassified to conform to the current period presentation. There was no impact on operating income.

Recent Accounting Pronouncements

Recently Issued

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 supersedes the revenue recognition requirements in “Topic 605, Revenue Recognition” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB issued a deferral of ASU 2014-09 of one year making it effective for annual reporting periods beginning on or after December 15, 2017 while also providing for early adoption not to occur before the original effective date. The Company is assessing the appropriate method for implementing ASU 2014-09, as well as the impact the adoption of ASU 2014-09 will have on its consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU 2016-02 amends existing leasing accounting requirements. The most significant change will result in the recognition of lease assets and lease liabilities by lessees for virtually all leases. The new guidance will also require significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Upon adoption, entities are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. Early adoption is permitted, and a number of optional practical expedients may be elected to simplify the impact of adoption. The Company is evaluating the impact of adopting this guidance.

In March 2016, the FASB issued ASU No. 2016-09, Compensation (Topic 718) Stock Compensation. ASU 2016-09 identifies areas for simplification involving several aspects of accounting for share-based payment transactions, including the income tax consequences, classification of awards as equity or liabilities, an option to recognize gross stock compensation expense with actual forfeitures recognized as they occur, as well as certain classifications on the statement of cash flows. Early adoption is permitted. The Company is assessing ASU 2016-09 and the impact that adopting this new accounting standard will have on its consolidated financial statements and footnote disclosures.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.

Recently Adopted

In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330) Simplifying the Measurement of Inventory. ASU 2015-11 more closely aligns the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The provisions of ASU 2015-11 are effective for annual and interim periods beginning after December 15, 2016. ASU 2015-11 should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The adoption of this amendment did not have a material impact on the Company’s financial position or results of operations.

Investments

All of the Company’s investments are classified as available-for-sale and are carried at fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income, net of related income taxes. The Company held bank certificates of deposit of $22.5 million and $25.8 million at June 30, 2016 and December 31, 2015, respectively. The Company also held corporate debt securities of $2.0 million at December 31, 2015. There were no unrealized gains or losses on the Company’s available-for-sale securities at June 30, 2016 or December 31, 2015.

Fair Value Measurements

Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability. As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows: (Level 1) observable inputs such as quoted prices in active markets for identical assets or liabilities; (Level 2) significant other observable inputs that are observable either directly or indirectly; and (Level 3) significant unobservable inputs for which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, the Company records its investments at fair value.

The Company’s investments are all classified within Level 2 of the fair value hierarchy. These investments classified within Level 2 of the fair value hierarchy are valued based on matrix pricing compiled by third party pricing vendors, using observable market inputs such as interest rates, yield curves, and credit risk.

The fair value hierarchy of the Company’s cash equivalents and investments at fair value is as follows:

			Fair Value Measurements at Reporting
			Date Using
			Quoted Prices in
			Active Markets		Significant Other		Significant
			for Identical Assets		Observable Inputs		Unobservable Inputs
	June 30, 2016		(Level 1)		(Level 2)		(Level 3)
Cash equivalents:
Money market funds	$	67,001	$	-	$	67,001	$	-

Investments:
Bank certificates of deposit	$	22,500	$	-	$	22,500	$	-


			Fair Value Measurements at Reporting
			Date Using
			Quoted Prices in
			Active Markets		Significant Other		Significant
			for Identical Assets		Observable Inputs		Unobservable Inputs
	December 31, 2015		(Level 1)		(Level 2)		(Level 3)
Cash equivalents:
Money market funds	$	61,385	$	-	$	61,385	$	-
Bank certificates of deposit		250		-		250		-
Total cash equivalents	$	61,635	$	-	$	61,635	$	-

Investments:
Corporate debt securities	$	2,001	$	-	$	2,001	$	-
Bank certificates of deposit		25,750		-		25,750		-
Total investments	$	27,751	$	-	$	27,751	$	-

Equity Incentive Plan

The Company estimates the fair value of stock options and stock appreciation rights (“SARs”) using the Black-Scholes valuation model. Fair value of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) are measured by the grant-date price of the Company’s shares. The fair value of each stock option award during the three- and six-month periods ended June 30, 2016 and 2015, respectively, was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Six Months Ended June 30,
	2016			2015
Risk free interest rate	0.94%	-	1.40%	1.15%	-	1.46%
Expected volatility	49.47%	-	51.61%	53.15%	-	54.65%
Expected life (years)		4.5			4.5
Expected dividend yield		0.00%			0.00%

The Company recorded $0.7 million and $0.5 million of share-based compensation expense for the three-month periods ended June 30, 2016 and 2015, respectively, for equity compensation awards. The Company recorded $1.5 million and $1.1 million of share-based compensation expense for the six-month periods ended June 30, 2016 and 2015, respectively, for equity compensation awards. The Company presents the expenses related to stock-based compensation awards in the same expense line items as cash compensation paid to the respective recipients.

During the three-month period ended June 30, 2016, the Company granted under the Equity Incentive Plan (“Plan”) a total of 43,000 stock options. During the six-month period ended June 30, 2016, the Company granted under the Plan a total of 331,705 stock options including 46,300 RSAs and 11,805 RSUs. All of the RSUs were granted to directors of the Company and vest over a one year period. The stock options and RSAs granted to employees generally become exercisable or vest ratably over four years from the date of grant.

A portion of the stock options granted during the six-month period ended June 30, 2016 contained certain performance features, as compared to established targets, in addition to time-based vesting conditions. For performance-based awards with financial achievement targets, the Company recognizes expense using the graded vesting methodology based on the number of shares expected to vest. Compensation cost associated with performance grants is estimated using the Black-Scholes valuation method multiplied by the expected number of shares to be issued, which is adjusted based on the estimated probabilities of achieving the performance goals. Changes to the probability assessment and the estimated shares expected to vest will result in adjustments to the related share-based compensation expense that will be recorded in the period of the change. If the performance targets are not achieved, no compensation cost is recognized and any previously recognized compensation cost is reversed.

Earnings Per Share (“EPS”)

Basic EPS is calculated by dividing net income by the weighted average number of shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic earnings per share. Diluted EPS is calculated by dividing net income by the weighted average number of shares outstanding plus the dilutive effect, if any, of outstanding stock options, SARs, RSAs, and RSUs using the treasury stock method.

The following table provides share information used in the calculation of the Company's basic and diluted earnings per share:

	Three Months Ended June 30,				Six Months Ended June 30,
	2016		2015		2016		2015
Shares used in the calculation of basic earnings per share		14,679		14,961		14,778		14,934
Effect of dilutive securities:
Stock options, SARs, and RSAs		432		375		432		398
Diluted shares used in the calculation of earnings per share		15,111		15,336		15,210		15,332

Equity awards of 0.3 million shares were outstanding for the three- and six-month periods ended June 30, 2016 and were not included in the computation of diluted earnings per share because the awards’ impact on earnings per share was anti-dilutive. Equity awards of 0.2 million shares were outstanding for the three- and six-month periods ended June 30, 2015, respectively, and were not included in the computation of diluted earnings per share because the awards’ impact on earnings per share was anti-dilutive.

On February 26, 2016, the Company entered into an accelerated stock repurchase agreement with Morgan Stanley & Co. LLC (“Morgan Stanley”) pursuant to a Fixed Dollar Accelerated Share Repurchase Transaction (“ASR Agreement") to purchase $25.0 million of shares of its common stock. Pursuant to the terms of the ASR Agreement, the Company paid Morgan Stanley $25.0 million in cash and received an initial delivery of 377,155 shares of the Company’s common stock on February 29, 2016 based on a closing market price of $46.40 and the applicable contractual discount. This is approximately 70% of the total number of shares of expected to be repurchased under the ASR Agreement. These shares are held by the Company as authorized but unissued shares pursuant to Massachusetts law. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted net income per share.

As of June 30, 2016, the Company has approximately $7.5 million remaining under the ASR Agreement which was recorded as an equity forward sale contract and was included in additional paid-in capital in stockholders' equity in the condensed consolidated balance sheet as it met the criteria for equity accounting. Pursuant to the terms of the ASR Agreement, the final number of shares and the average purchase price will be determined at the end of the applicable purchase period, which is expected to occur in the third quarter of 2016. Upon settlement of the ASR Agreement, the Company may receive additional shares or be required to either pay additional cash or deliver shares of our common stock (at its option) to Morgan Stanley, based on the forward price. If the ASR Agreement had been settled as of June 30, 2016, based on the volume-weighted average price since the effective date of the ASR Agreement, Morgan Stanley would have been required to deliver approximately 0.2 million additional shares to the Company. However, the Company cannot predict the final number of shares to be received, or delivered, by it under the ASR Agreement, and, as such, these shares are not included in the calculation of diluted weighted-average common shares outstanding during the period because the effect is anti-dilutive.

Inventories

Inventories consist of the following:

	June 30,		December 31,
	2016		2015
Raw materials	$	6,812	$	5,780
Work-in-process		6,140		5,656
Finished goods		4,312		3,502
Total	$	17,264	$	14,938

Inventories are stated at the lower of cost or market, with cost being determined using the first-in, first-out method. Work-in-process and finished goods inventories include materials, labor, and manufacturing overhead. Inventory costs associated with product candidates that have not yet received regulatory approval are capitalized if the Company believes there is probable future commercial use and future economic benefit.

Intangible Assets

In connection with the 2009 acquisition of Anika Therapeutics S.r.l. (“Anika S.r.l.”), the Company acquired various intangible assets and goodwill. The Company evaluated the various intangible assets and related cash flows from these intangible assets, as well as the useful lives and amortization methods related to these intangible assets. The in-process research and development (“IPR&D”) intangible assets initially have indefinite lives and are reviewed periodically to assess the project status, valuation, and disposition, including write-off(s) for abandoned projects. Until such determination is made, they are not amortized.

Intangible assets as of June 30, 2016 and December 31, 2015 consist of the following:

			June 30, 2016								December 31, 2015
	Gross Value		Accumulated Currency Translation Adjustment			Accumulated Amortization			Net Book Value		Net Book Value		Useful Life
Developed technology	$	17,100	$	(3,108	)	$	(6,373	)	$	7,619	$	7,959		15
In-process research & development		4,406		(1,286	)		-			3,120		3,099		Indefinite
Distributor relationships		4,700		(415	)		(4,285	)		-		-		5
Patents		1,000		(186	)		(357	)		457		473		16
Elevess trade name		1,000		-			(937	)		63		125		9
Total	$	28,206	$	(4,995	)	$	(11,952	)	$	11,259	$	11,656

The aggregate amortization expense related to intangible assets was $0.3 million for the three-month periods ended June 30, 2016 and 2015, respectively. The aggregate amortization expense related to intangible assets was $0.6 million and $0.5 million for the six-month periods ended June 30, 2016 and 2015, respectively.

10.

Goodwill

Through June 30, 2016, there have not been any events or changes in circumstances that indicate that the carrying value of goodwill may not be recoverable. Changes in the carrying value of goodwill were as follows:

	Six Months Ended June 30,		Twelve Months Ended December 31,
	2016		2015

Balance, beginning	$	7,482	$	8,339
Effect of foreign currency adjustments		86		(857	)
Balance, ending	$	7,568	$	7,482

11.

Accrued Expenses

Accrued expenses consist of the following:

	June 30,		December 31,
	2016		2015
Compensation and related expenses	$	2,416	$	3,082
Facility construction costs		1,769		415
Research grants		481		381
Professional fees		889		210
Clinical trial costs		339		252
Other		744		438
Total	$	6,638	$	4,778

12.

Commitments and Contingencies

In certain of its contracts, the Company warrants to its customers that the products it manufactures conform to the product specifications as in effect at the time of delivery of the specific product. The Company may also warrant that the products it manufactures do not infringe, violate, or breach any U.S. patent or intellectual property right, trade secret, or other proprietary information of any third party. On occasion, the Company contractually indemnifies its customers against any and all losses arising out of, or in any way connected with, any claim or claims of breach of its warranties or any actual or alleged defect in any product caused by the negligent acts or omissions of the Company. The Company maintains a products liability insurance policy that limits its exposure to these risks. Based on the Company’s historical activity, in combination with its liability insurance coverage, the Company believes the estimated fair value of these indemnification agreements is immaterial. The Company had no accrued warranties at June 30, 2016 or December 31, 2015, respectively, and has no history of claims paid.

The Company is also involved in various legal proceedings arising in the normal course of business. Although the outcomes of these legal proceedings are inherently difficult to predict, the Company does not expect the resolution of these legal proceedings to have a material adverse effect on its financial position, results of operations, or cash flow.

13.

Leases

On October 9, 2015, Anika S.r.l. entered into a build-to-suit lease agreement with Consorzio Zona Industriale E Porto Fluviale di Padova (“ZIP”), as landlord, pursuant to which Anika S.r.l. will lease a new European headquarters facility, consisting of approximately 33,000 square feet of general office, research and development, training, and warehousing space located in Padova, Italy. The lease has an initial term of fifteen years, which is expected to commence during the fourth quarter of 2016 once construction of the facility is completed. The lease will automatically renew for up to three additional six-year terms, subject to certain terms and conditions. The Company has the ability to withdraw from this lease subject to certain financial penalties after six years and with no penalties after the ninth year. Beginning on the commencement date, the lease provides for an initial yearly rent of approximately $0.4 million.

Construction of the new facility began in the first quarter of 2016 and is expected to be completed in late 2016. During the period of construction the Company is considered the deemed owner of the facility. Accordingly, the landlord's costs of constructing the facility are required to be capitalized, as a non-cash transaction, offset by a corresponding facility lease obligation in the Company’s consolidated balance sheet. As of June 30, 2016, the Company has recorded a construction-in-process asset of approximately $0.9 million. This includes $0.5 million incurred by ZIP for the construction of the new facility, which was recorded as a facility lease obligation within other long-term liabilities on the balance sheet.

14.

Income Taxes

Provisions for income taxes were $4.9 million and $8.8 million for the three- and six-month periods ended June 30, 2016, based on effective tax rates of 36.3% and 36.2%, respectively. Provisions for income taxes were $4.6 million and $6.6 million for the three- and six-month periods ended June 30, 2015, based on effective tax rates of 37% for both periods. The increase in income taxes for the three- and six-month period ended June 30, 2016 resulted from higher net income as compared to the same periods in the prior year. The net decrease in the effective tax rate for the three- and six-month period ended June 30, 2016, as compared to the same period in 2015, was primarily due to an increase in the expected tax credit for research and development expenditures.

The Company files income tax returns in the United States on a federal basis, in certain U.S. states, and in Italy. The associated tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. The Company’s filings from 2012 through the present tax year remain subject to examination by the IRS and other taxing authorities for U.S. federal and state tax purposes. The Company currently has a tax audit in progress in the United States and does not anticipate that the audit will have a material impact on its financial statements. The Company’s filings from 2010 through the present tax year remain subject to examination by the appropriate governmental authorities in Italy.

In connection with the preparation of the financial statements, the Company performed an analysis to ascertain if it was more likely than not that it would be able to utilize, in future periods, the net deferred tax assets associated with its net operating loss carryforward. The Company concluded that the positive evidence outweighs the negative evidence and, thus, those deferred tax assets are realizable on a “more likely than not” basis. As such, the Company did not record a valuation allowance at June 30, 2016 or December 31, 2015.

15.

Segment and Geographic Information

The Company has one reportable operating segment, for the purposes of assessing performance and deciding how to allocate resources.

Product revenue by product group is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2016		2015		2016		2015
Orthobiologics	$	23,304	$	19,283	$	42,891	$	31,255
Surgical		1,433		1,647		2,751		3,037
Dermal		582		303		963		719
Other		1,256		1,665		2,248		3,402
Product Revenue	$	26,575	$	22,898	$	48,853	$	38,413

Total revenue by geographic location and as a percentage of overall total revenue for the three-month periods ended June 30, 2016 and 2015 are as follows:

	Three Months Ended June 30,
	2016					2015
	Total		Percentage of			Total		Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	21,895		82	%	$	19,218		84	%
Europe		2,977		11	%		2,331		10	%
Other		1,709		7	%		1,355		6	%
Total Revenue	$	26,581		100	%	$	22,904		100	%

	Six Months Ended June 30,
	2016					2015
	Total		Percentage of			Total		Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	39,906		82	%	$	31,809		83	%
Europe		5,542		11	%		4,317		11	%
Other		3,416		7	%		2,298		6	%
Total	$	48,864		100	%	$	38,424		100	%

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (amounts in thousands, except per share amounts or as otherwise noted)

You should read the following discussion in conjunction with our financial statements and related notes appearing elsewhere in this report. In addition to historical information, this discussion contains forward-looking statements that involve risks, uncertainties, and assumptions that could cause our actual results to differ materially from our expectations. Words such as “will,” “likely,” “may,” “believe,” “expect,” “anticipate,” “intend,” “seek,” “designed,” “develop,” “would,” “future,” “can,” “could,” and other expressions that are predictions of or indicate future events and trends and which do not relate to historical matters are intended to identify such forward-looking statements. These statements are likely to relate to, among other things, our goals, plans and projections regarding our financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, performance, and results related to current or anticipated products. You should carefully consider forward-looking statements and understand that such statements may be affected by inaccurate assumptions and may involve a variety of risks and uncertainties, known and unknown, including, among others, risks related to competition in the medical device industry, reduction or interruption in our supply, quality problems, decreasing prices, changes in applicable tax rates, adverse regulatory action, health care policy changes, international operations, or disruption of our current plans and operations, as well as those factors described in Part II, Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2015, and as may be updated in our subsequent Quarterly Reports on Form 10-Q. Consequently, no forward-looking statements can be guaranteed and actual results may vary materially, and you should take caution not to place undue reliance on such statements. We undertake no obligation to release publicly any revisions to forward-looking statements as a result of new information, future events, or otherwise.

Management Overview

We are a global, integrated orthopedic medicines company committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions by providing innovative and differentiated therapeutic pain management solutions along the continuum of care, from palliative care to regenerative medicine. We have over two decades of expertise developing, manufacturing, and commercializing our products, in markets across the globe, based on our proprietary hyaluronic acid (“HA”) technology. Our orthopedic medicine portfolio is comprised of marketed (ORTHOVISC and MONOVISC) and pipeline (CINGAL and HYALOFAST in the United States, among others) products to alleviate pain and restore joint function by replenishing depleted HA and aiding cartilage repair and regeneration.

Our therapeutic offerings consist of products in the following areas: Orthobiologics, Dermal, Surgical, Ophthalmic, and Veterinary. All of our products are based on HA, a naturally occurring, biocompatible polymer found throughout the body. Due to its unique biophysical and biochemical properties, HA plays an important role in a number of physiological functions such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to and within cells.

Our proprietary technologies for modifying the HA molecule allow product properties to be tailored specifically to therapeutic use. Our patented technology chemically modifies HA to allow for longer residence time in the body. We also offer products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Our technologies are protected by an extensive portfolio of owned and licensed patents.

Since our inception in 1992, we have utilized a commercial partnership model for the distribution of our products to end-users. Our strong, worldwide network of distributors has historically provided, and continues to provide, a solid foundation for our revenue growth and territorial expansion. In 2015, we made the strategic decision to commercialize our next generation viscosupplementation product, CINGAL, in the United States ourselves, initially through the engagement of a contract sales organization. Ultimately, we intend to transition the direct sales function into our company as part of a broader buildout of our commercial capabilities. We believe that the combination of the direct and distribution commercial models will maximize the revenue potential from our current and future product portfolio.

We began a strategic project in 2015 to move the manufacturing of our HYAFF-based products, which currently are manufactured by a third party in Italy, to our Bedford, Massachusetts facility. Our main purposes behind this strategic move are to improve the efficiency of our manufacturing process and to enhance our research and development capabilities, with the aim of accelerating future product development. We expect to expend approximately $25 million on this project.

Please see the section captioned “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations-Management Overview” in our Annual Report on Form 10-K for the year ended December 31, 2015, for a description of each of the above therapeutic areas, including the individual products.

Research and Development

Our research and development efforts primarily consist of the development of new medical applications for our HA-based technology, the management of clinical trials for certain product candidates, the preparation and processing of applications for regulatory approvals or clearances at all relevant stages of product development, and process development and scale-up manufacturing activities for our existing and new products. Our development focus includes products for tissue protection, repair, and regeneration. We anticipate that we will continue to commit significant resources to research and development, including in relation to clinical trials, in the future.

Our second single-injection osteoarthritis product under development is CINGAL, which is composed of our proprietary cross-linked HA material combined with an approved steroid and is designed to provide both short- and long-term pain relief to patients. We completed the CINGAL phase III clinical trial and associated statistical analysis during the fourth quarter of 2014. During the first half of 2015, we completed a CINGAL retreatment study with patients who had participated in the phase III clinical trial and reported safety data related to the retreatment study. We received approval for CINGAL from Health Canada in November 2015 for the treatment of pain in osteoarthritis of the knee. In March 2016, we received CE Mark approval of CINGAL as a viscoelastic supplement or as a replacement for synovial fluid in human joints. We successfully achieved commercial launch of the product in Canada during May 2016 and in the European Union during June 2016. In the United States, after discussions with the FDA related to the regulatory pathway for CINGAL, we conducted a formal meeting with the FDA’s Office of Combination Products (“OCP”) to present and discuss our data in September 2015, and we submitted a formal request for designation with OCP a month later. In its response to our formal request for designation, OCP assigned the product to the FDA’s Center for Drug Evaluation and Research (“CDER”) as the lead agency center for premarket review and regulation. Since then, we have been in ongoing discussions with CDER to understand the requirements for submitting a New Drug Application (“NDA”) for CINGAL, and preliminary indications from CDER suggested that additional clinical work may be required. We are employing multiple approaches to obtain definitive feedback with respect to our prospective NDA, and we plan to meet with the FDA to collaboratively discuss this topic.

We have several research and development programs underway for new products, including for HYALOFAST (in the United States), an innovative product for cartilage tissue repair, HYALOBONE, a bone void filler, and other early stage regenerative medicine development programs. HYALOFAST received CE Mark approval in September 2009, and it is commercially available in Europe and certain international countries. During the first quarter of 2015, we submitted an Investigational Device Exemption (“IDE”) for HYALOFAST to the FDA, which was approved in July 2015. We commenced patient enrollment in a clinical trial in December 2015, and we are advancing site initiations and patient enrollment activities. In the second quarter of 2016, a supplement to the HYALOFAST IDE was approved to expand the inclusion criteria for the clinical study. The purpose of this supplement is to allow us to increase enrollment rates with the ultimate goal of decreasing the time needed to complete the clinical trial. We are also currently proceeding with other research and development programs, one of which utilizes our proprietary HA technology to treat pain associated with common repetitive overuse injuries, such as those to the elbow, rotator cuff and Achilles tendon. We submitted a CE mark application for this treatment during the first quarter of 2016, and we expect approval of this application during the first half of 2017. Additionally, in the second quarter of 2016, we submitted an IDE to the FDA to conduct a phase III pivotal clinical trial for this treatment, which was approved by the FDA in June 2016.

In June 2015, we entered into an agreement with the Institute for Applied Life Sciences at the University of Massachusetts Amherst to collaborate on research to develop a therapy for rheumatoid arthritis. The purpose of this research is to develop a novel modality for the treatment of rheumatoid arthritis, and if successful, it is expected to yield a potential product candidate that we could begin to move towards commercialization as early as 2017.

Results of Operations

Three and Six Months Ended June 30, 2016 Compared to Three and Six Months Ended June 30, 2015

	Three Months Ended June 30,									Six Months Ended June 30,
	2016		2015		$ Inc/(Dec)		% Inc/(Dec)			2016		2015		$ Inc/(Dec)		% Inc/(Dec)
	(in thousands, except percentages)									(in thousands, except percentages)
Product revenue	$	26,575	$	22,898	$	3,677		16	%	$	48,853	$	38,413	$	10,440		27	%
Licensing, milestone and contract revenue		6		6		-		0	%		11		11		-		0	%
Total revenue		26,581		22,904		3,677		16	%		48,864		38,424		10,440		27	%

Operating expenses:
Cost of product revenue		6,065		5,275		790		15	%		11,490		9,588		1,902		20	%
Research & development		2,792		1,812		980		54	%		4,951		3,910		1,041		27	%
Selling, general & administrative		4,255		3,388		867		26	%		8,245		6,993		1,252		18	%
Total operating expenses		13,112		10,475		2,637		25	%		24,686		20,491		4,195		20	%
Income from operations		13,469		12,429		1,040		8	%		24,178		17,933		6,245		35	%
Interest income, net		49		24		25		105	%		121		48		73		152	%
Income before income taxes		13,518		12,453		1,065		9	%		24,299		17,981		6,318		35	%
Provision for income taxes		4,903		4,634		269		6	%		8,789		6,646		2,143		32	%
Net income	$	8,615	$	7,819	$	796		10	%	$	15,510	$	11,335	$	4,175		37	%
Product gross profit	$	20,510	$	17,623	$	2,887		16	%	$	37,363	$	28,825	$	8,538		30	%
Product gross margin		77%		77%							77%		75%

Product Revenue

Product revenue for the quarter ended June 30, 2016 was $26.6 million, an increase of 16% as compared to $22.9 million for the quarter ended June 30, 2015. Product revenue for the six-month period ended June 30, 2016 was $48.9 million, an increase of 27% as compared to $38.4 million for the six-month period ended June 30, 2015. For the three-month period ended June 30, 2016, the increase in product revenue was driven by our orthobiologics franchise, and such increase was partially offset by decreases in our surgical and other product revenue as a result of the timing of orders for our veterinary products. For the six-month period ended June 30, 2016, we saw orthobiologics and dermal product revenue growth, both domestically and internationally, while surgical product revenue decreased slightly year-over-year primarily related to our ear, nose, and throat (“ENT”) anti-adhesion products. Included in product revenue for the second quarter of 2015 was approximately $1.8 million of non-recurring revenue related to a high end-user average selling price for MONOVISC products sold to our U.S. partner, DePuy Synthes Mitek Sports Medicine (“Mitek”), prior to the fourth quarter of 2014. The amount was agreed with Mitek during the second quarter of 2015, and MONOVISC product sold to Mitek after the third quarter of 2014 is not impacted by this arrangement.

The following tables present product revenue by group for the three- and six-month periods ended June 30, 2016 and 2015:

	Three Months Ended June 30,
	2016		2015		$ Inc/(Dec)			% Inc/(Dec)
	(in thousands, except percentages)
Orthobiologics	$	23,304	$	19,283	$	4,021			21	%
Surgical		1,433		1,647		(214	)		(13	%)
Dermal		582		303		279			92	%
Other		1,256		1,665		(409	)		(25	%)
Total	$	26,575	$	22,898	$	3,677			16	%

	Six Months Ended June 30,
	2016		2015		$ Inc/(Dec)			% Inc/(Dec)
	(in thousands, except percentages)
Orthobiologics	$	42,891	$	31,255	$	11,636			37	%
Surgical		2,751		3,037		(286	)		(9	%)
Dermal		963		719		244			34	%
Other		2,248		3,402		(1,154	)		(34	%)
Total	$	48,853	$	38,413	$	10,440			27	%

Orthobiologics

Our orthobiologics franchise consists of our joint health and orthopedic products. Overall, sales increased 21% and 37% for the three- and six- month periods ended June 30, 2016, as compared to the same periods in 2015. The growth in the second quarter of 2016 reflected a significant increase in product purchases as compared with the same period in the prior year during which our U.S. commercial partner implemented a multi-month inventory reset program. Product sales to our U.S. commercial partner, Mitek, in the second quarter of 2016 increased by approximately $2.7 million as compared to the second quarter of 2015. The volume gain was partially offset by the impact of pricing concessions by our commercial partner aimed at growing market share. More importantly, we also experienced growing end-user demand during the first half of 2016, resulting in increased revenue from worldwide orthobiologics sales, including a 47% increase in international orthobiologics revenue as compared to the same period in 2015. We expect orthobiologics revenue to continue to grow in 2016, led by increased MONOVISC revenue in the United States, the commercial availability of CINGAL in Canada and Europe, as well as overall revenue growth from our viscosupplementation products both domestically and internationally.

Surgical

Our surgical franchise consists of products used to prevent surgical adhesions and to treat ENT disorders. Sales of our surgical products decreased 13% and 9% for the three- and six-month periods ended June 30, 2016 to $1.4 million and $2.8 million, respectively, as compared to the same periods in 2015. The decrease in surgical product revenue for the three- and six-month periods was primarily due to the unfavorable impact from foreign currency exchange rate fluctuations and the inventory releveling by our worldwide ENT commercial partner. As a result of these factors, we expect surgical product revenue to decrease moderately for the full-year 2016 compared to 2015.

Dermal

Our dermal franchise consists of advanced wound care products, which are based on the HYAFF technology, and aesthetic dermal fillers. Our advanced wound care products treat complex skin wounds ranging from burns to diabetic ulcers, with HYALOMATRIX and HYALOFILL as the lead products. For the three- and six-month periods ended June 30, 2016, dermal product sales increased 92% and 34% as compared to the same periods in 2015. This increase reflects rising domestic and international end-user demand, as well as order timing by our distribution partners. We expect advanced wound care revenue to increase for the full-year 2016 as compared to 2015 primarily due to increased end-user demand, increased U.S. reimbursement coverage, and geographic expansion, particularly in the U.S., European, and Latin American markets.

Other

Other product revenue includes revenues from our ophthalmic and veterinary franchises. Product revenue from each of these franchises decreased for the three- and six-month periods ended June 30, 2016 as compared to the same periods in 2015, except for ophthamalic product revenue, which increased for the three-month period ended June 30, 2016. We expect other product revenue to decrease for the full-year 2016, as compared to 2015, primarily as a result of lower veterinary revenue.

Product gross profit and margin

Product gross profit for the three- and six-month periods ended June 30, 2016 increased $2.9 million and $8.5 million to $20.5 and $37.4 million, respectively, or 77% of product revenue for both periods. Product gross profit for the three- and six- months ended June 30, 2015 was $17.6 million and $28.8 million, or 77% and 75% of product revenue for each period, respectively. The increase in product gross margin for the three-month period ended June 30, 2016, as compared to the same period in 2015, was primarily attributable to the overall product mix compared to the prior year, with sales of our higher-margin orthobiologics products accounting for a larger percentage of our total product sales. This quarter’s product gross margin may not be indicative of the rest of the year due to dynamics such as future revenue mix.

Research and development

Research and development expenses for the three- and six-month periods ended June 30, 2016 were $2.8 million and $5.0 million, or 11% and 10% of total revenue for the respective periods, representing an increase of $1.0 million for both periods as compared to the same periods in 2015. The increase in research and development expenses was primarily due to the timing and the higher level of clinical activities associated with the HYALOFAST phase III study, which commenced in December 2015. Furthermore, we also increased our pre-clinical product development activities, including with respect to the CE Mark application and IDE for our program which seeks to utilize our proprietary HA technology to treat pain associated with common repetitive overuse injuries, such as those to the elbow, rotator cuff and Achilles tendon. Research and development spending is expected to increase in 2016, and for the foreseeable future, as compared to 2015, as we further develop new products and initiate new clinical trials based on our existing technology assets, including HYALOFAST, as well as increase development activities for other products in our pipeline.

Selling, general, and administrative

Selling, general, and administrative (“SG&A”) expenses for the three- and six-month periods ended June 30, 2016 were $4.3 million and $8.2 million, representing 16% and 17% of total revenue for the periods, an increase of $0.9 million and $1.3 million, respectively, as compared to the same periods in 2015. SG&A expenses increased for the three- and six-month periods ending June 30, 2016 primarily as a result of increases in personnel related costs, marketing initiatives to support CINGAL international launches, and external professional fees. We expect selling, general, and administrative expenses for 2016 will increase to reflect the support required to grow our business, both domestically and internationally.

Income taxes

Liquidity and Capital Resources

We expect that our requirements for cash to fund operations and capital expenditures will increase as the scope of our operations expands. Historically, we have generated positive cash flow from operations, which together with our available cash and investments have met our cash requirements. Cash, cash equivalents, and investments totaled approximately $111.6 million and $138.5 million at June 30, 2016 and December 31, 2015, respectively. Working capital totaled approximately $144.1 million at June 30, 2016 and $159.2 million at December 31, 2015. We believe that we have adequate financial resources to support our business for at least the next twelve months.

Cash provided by operating activities was $6.6 million for the six months ended June 30, 2016, as compared to cash provided by operating activities of $14.9 million for the same period in 2015. The decrease in cash provided by operations was due primarily to a decrease in net working capital, as compared to the same period in 2015, primarily related to the planned inventory build resulting from the transfer of outsourced contract manufacturing from Italy to our Bedford, Massachusetts facility, and a decrease in income taxes payable due to the timing of payments.

Cash used in investing activities was $4.6 million for the six months ended June 30, 2016, as compared to cash used in investing activities of $12.9 million for the same period in 2015. The decrease in cash used in investing activities was primarily the result of the purchase of investments offset by maturities of investments during the first half of 2016, as well as increased expenditures on capital equipment. We expect an increase in investing activities for the full year 2016 as a result of our on-going project to establish the additional manufacturing capabilities at the Bedford, Massachusetts facility required to manufacture our HYAFF-based products, which were previously manufactured by a third party in Italy. During the quarter ended June 30, 2016, we expended approximately $2.2 million for this project. We expect to expend approximately an additional $5.1 million on this project over the course of the next 12 months.

Cash used in financing activities was $23.7 million for the six months ended June 30, 2016, as compared to cash provided by financing activities totaling $1.9 million for the same period in 2015. The increase in cash used in financing activities for the six months ended June 30, 2016 was primarily attributable to the Fixed Dollar Accelerated Share Repurchase Transaction to purchase $25.0 million of shares of our common stock. Pursuant to the terms of the ASR Agreement, we paid Morgan Stanley $25.0 million in cash and received an initial delivery of 377,155 shares of our common stock on February 29, 2016 based on the closing market price of $46.40 and the related applicable discount.

Critical Accounting Estimates

There were no other significant changes in our critical accounting estimates during the three months ended June 30, 2016, as compared to the critical accounting estimates disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

Recent Accounting Pronouncements

A discussion of Recent Accounting Pronouncements is included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 and updated in Note 3 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Contractual Obligations and Other Commercial Commitments

Our contractual obligations and other commercial commitments are summarized in the section captioned “Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2015. We had no material changes outside the ordinary course to our contractual obligations, as reported in our 2015 Annual Report on Form 10-K, during the first six months of 2016.

To the extent that funds generated from our operations, together with our existing capital resources, are insufficient to meet future requirements, we will be required to obtain additional funds through equity or debt financings, strategic alliances with corporate partners and others, or through other sources. No assurance can be given that any additional financing will be made available to us or will be available on acceptable terms should such a need arise.

Off-balance Sheet Arrangements

We do not use special purpose entities or other off-balance sheet financing techniques, except for operating leases, that we believe have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, or capital resources.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our market risks, and the ways we manage them, are summarized in the section captioned “Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2015. There have been no material changes in the first six months of 2016 to our market risks or to our management of such risks.

ITEM 4.

CONTROLS AND PROCEDURES

(a)

Evaluation of disclosure controls and procedures.

As required by Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we carried out an evaluation under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the chief executive officer and chief financial officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in SEC rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports it files or submits under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. On an on-going basis, we review and document our disclosure controls and procedures, and our internal control over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our systems evolve with our business.

(b)

Changes in internal controls over financial reporting.

There were no changes in our internal control over financial reporting during the three-month period ended June 30, 2016 that have materially affected, or that are reasonably likely to materially affect, our internal controls over financial reporting.

PART II: OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We are involved in various legal proceedings arising in the normal course of business. Although the outcomes of these legal proceedings are inherently difficult to predict, we do not expect the resolution of these legal proceedings to have a material adverse effect on our financial position, results of operations, or cash flow. There have been no material changes to the information provided in the section captioned “Part I, Item 3, Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31, 2015.

ITEM 1A.

RISK FACTORS

There have been no material changes to the risk factors described in the section captioned “Part I, Item 1A, Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015. In addition to the other information set forth in this report, you should carefully consider the factors discussed in the section captioned “Part I, Item 1A, Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015, which could materially affect our business, financial condition, or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may have a material adverse effect on our business, financial condition, and/or operating results.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The following table provides information about purchases by us during the quarter ended June 30, 2016 of shares of our common stock.

Period	Total Number of Shares Repurchased ⁽¹⁾		Average Price Paid per Share ⁽¹⁾		Total Number of Shares Repurchased as Part of Publicly Announced Program ⁽¹⁾		Approximate Dollar Value of Shares that May Yet Be Repurchased Under the Program ⁽¹⁾
April 1 to 30, 2016		-		-		-	$	7,500
May 1 to 31, 2016		-		-		-		7,500
June 1 to 30, 2016		-		-		-		7,500
Total		-		-		-		-

(1)

On March 2, 2016, we publicly announced that on February 26, 2016 we had entered into the ASR Agreement to repurchase an aggregate of $25.0 million of our common stock. During the first quarter of 2016, 377,155 shares were delivered to us under the ASR Agreement, constituting the initial delivery of shares under the ASR Agreement. Pursuant to the terms of the ASR Agreement, the final number of shares and the average purchase price per share will be determined at the end of the applicable purchase period, which is expected to occur in or before August 2016. All shares were repurchased in accordance with the publicly announced program.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

Not Applicable.

ITEM 4.

MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 6.

EXHIBITS

Exhibit No.		Description

		Restated Articles of Organization, as amended, of Anika Therapeutics, Inc. (with date of filing with Secretary of State of the Commonwealth of Massachusetts):
3.1a		Restated Articles of Organization (April 29, 1993), incorporated herein by reference to Exhibit 3.1a to Form 10-K, filed with SEC on March 13, 2015
3.1b		Certificate of Correction (November 10, 1993), incorporated herein by reference to Exhibit 3.1b to Form 10-K, filed with SEC on March 13, 2015
3.1c		Certificate of Vote of Directors Establishing a Series of a Class of Stock (May 18, 1995), incorporated herein by reference to Exhibit 3.1c to Form 10-K, filed with SEC on March 13, 2015
3.1d		Articles of Amendment (January 9, 1997), incorporated herein by reference to Exhibit 3.1 to Form 10-QSB, filed with SEC on January 14, 1997
3.1e		Certificate of Vote of Directors Establishing a Series of a Class of Stock (April 7, 1998), incorporated herein by reference to Exhibit 3.1e to Form 10-K, filed with SEC on March 13, 2015
3.1f		Articles of Amendment (June 3, 1998), incorporated herein by reference to Exhibit 3.1 to Form 10-QSB, filed with SEC on August 13, 1998
3.1g		Articles of Amendment (April 4, 2008), incorporated herein by reference to Exhibit 3.7 to Form 10-K, filed with SEC on March 9, 2009
*3.1h		Articles of Amendment (June 8, 2016)
(31)		Rule 13a-14(a)/15d-14(a) Certifications


*31.1	Certification of Charles H. Sherwood, Ph.D., pursuant to Rules 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

*31.2	Certification of Sylvia Cheung pursuant to Rules 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

(32)	Section 1350 Certifications

**32.1	Certification of Charles H. Sherwood, Ph.D., and Sylvia Cheung, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(101)	XBRL

*101	The following materials from Anika Therapeutics, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, as filed with the SEC on August 1, 2016, formatted in XBRL (eXtensible Business Reporting Language), as follows:
	i.	Condensed Consolidated Balance Sheets as of June 30, 2016 (unaudited) and December 31, 2015 (unaudited)
	ii.	Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Six Months Ended June 30, 2016 and June 30, 2015 (unaudited)
	iii.	Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2016 and June 30, 2015 (unaudited)
	iv.	Notes to Condensed Consolidated Financial Statements (unaudited)

*	Filed herewith
**	Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		ANIKA THERAPEUTICS, INC.

Date: August 1, 2016	By:	/s/ SYLVIA CHEUNG
		Sylvia Cheung
		Chief Financial Officer
		(Authorized Officer and Principal Financial Officer)

EX-3.1H 2 exh_3.htm EXHIBIT 3.1H

Exhibit 3.1h

EX-31.1 3 exh_311.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION

I, Charles H. Sherwood, certify that:

	1.	I have reviewed this report on Form 10-Q for the quarterly period ended June 30, 2016 of Anika Therapeutics, Inc.;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2016	/s/ CHARLES H. SHERWOOD
	Charles H. Sherwood, Ph.D.
	Chief Executive Officer
	Principal Executive Officer

EX-31.2 4 exh_312.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION

I, Sylvia Cheung, certify that:

I have reviewed this report on Form 10-Q for the quarterly period ended June 30, 2016 of Anika Therapeutics, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2016	/s/ SYLVIA CHEUNG
	Sylvia Cheung
	Chief Financial Officer
	Principal Financial Officer

EX-32.1 5 exh_321.htm EXHIBIT 32.1

Exhibit 32.1

Section 906 Certification

The undersigned officers of Anika Therapeutics, Inc. (the “Company”) hereby certify to their knowledge and in their respective capacities that the Company’s quarterly report on Form 10-Q to which this certification is attached (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 1, 2016	/s/ CHARLES H. SHERWOOD
	Charles H. Sherwood, Ph.D.
	Chief Executive Officer
	Principal Executive Officer

Date: August 1, 2016	/s/ SYLVIA CHEUNG
	Sylvia Cheung
	Chief Financial Officer
	Principal Financial Officer

This certification shall not be deemed “filed” for any purpose, nor shall it be deemed to be incorporated by reference into any filing, under the Securities Act of 1933, as amended, or the Exchange Act.

EX-101.INS 6 anik-20160630.xml XBRL INSTANCE FILE 339000 252000 481000 381000 -3108000 -1286000 -415000 -186000 -4995000 500000 69000 69000 P6Y P9Y 400000 3 P6Y P15Y 20 0.82 0.84 0.11 0.1 0.07 0.06 1 1 0.82 0.83 0.11 0.11 0.07 0.06 1 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse;; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Accumulated Currency Translation Adjustment</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Accumulated Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Net Book Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Net Book Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Useful Life</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; font-size: 10pt; text-align: left">Developed technology</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">17,100</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">(3,108</td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">(6,373</td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">7,619</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">7,959</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: center">15</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">In-process research & development</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">4,406</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">(1,286</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">3,120</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">3,099</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: center">Indefinite</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Distributor relationships</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">4,700</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">(415</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">(4,285</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: center">5</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Patents</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">1,000</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">(186</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">(357</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">457</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">473</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: center">16</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Elevess trade name</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,000</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(937</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">63</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">125</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: center">9</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.25pt; text-indent: 10pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">28,206</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(4,995</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(11,952</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">11,259</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">11,656</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="padding-bottom: 2.25pt; font-size: 10pt; text-align: left"> </td> <td style="padding-bottom: 2.25pt; font-size: 10pt; text-align: right"> </td> <td style="padding-bottom: 2.25pt; font-size: 10pt; text-align: left"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse;; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended June 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Geographic Location:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; text-indent: 10pt">United States</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">21,895</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">82</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">19,218</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">84</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Europe</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,977</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">11</td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,331</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">10</td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,709</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,355</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 20pt">Total Revenue</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">26,581</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,904</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse;; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Geographic Location:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; text-indent: 10pt">United States</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">39,906</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">82</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">31,809</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">83</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Europe</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">5,542</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">11</td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">4,317</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">11</td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,416</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,298</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 20pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">48,864</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">38,424</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr> </table></div> 0.7 false --12-31 Q2 2016 2016-06-30 10-Q 0000898437 14777663 Yes Accelerated Filer Anika Therapeutics, Inc. No No anik

46.40

3294000

8302000

24597000

21652000

591000

4198000

6638000

4778000

6638000

4778000

889000

210000

-6410000

-6649000

59506000

81685000

220000

167000

300000

600000

500000

300000

200000

33000

222738000

235748000

154644000

176433000

22500000

25800000

2000000

2128000

116000

89125000

110707000

100156000

103920000

67001000

61385000

250000

61635000

-21582000

3764000

0.01

60000000

30000000

14777663

15035808

14777663

15035808

148000

150000

8079000

8236000

15748000

9504000

900000

1769000

415000

6065000

5275000

11490000

9588000

13112000

10475000

24686000

20491000

-252000

-428000

56000

66000

6570000

6775000

1901000

1827000

0.59

0.52

1.05

0.76

0.57

0.51

1.02

0.74

52000

-121000

0.363

0.362

0.37

2416000

3082000

419000

934000

419000

934000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse;; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center">Fair Value Measurements at Reporting</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Date Using</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Quoted Prices in</td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Active Markets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant Other</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">for Identical Assets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Observable Inputs</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Unobservable Inputs</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2016</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 1)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 2)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 3)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Cash equivalents:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Money market funds</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">67,001</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">67,001</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Investments:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Bank certificates of deposit</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,500</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,500</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse;; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center">Fair Value Measurements at Reporting</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Date Using</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Quoted Prices in</td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Active Markets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant Other</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">for Identical Assets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Observable Inputs</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Unobservable Inputs</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 1)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 2)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 3)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Cash equivalents:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left">Money market funds</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">61,385</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">61,385</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Bank certificates of deposit</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">250</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">250</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total cash equivalents</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">61,635</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">61,635</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Investments:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Corporate debt securities</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">2,001</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">2,001</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Bank certificates of deposit</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,750</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,750</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total investments</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">27,751</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">27,751</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-weight: bold;">5.</div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Fair Value Measurements</div></td> </tr> </table> <div style=" font-size: 10pt; text-indent: 0.55in; margin: 0pt 0">Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability. As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows: (Level 1) observable inputs such as quoted prices in active markets for identical assets or liabilities; (Level 2) significant other observable inputs that are observable either directly or indirectly; and (Level 3) significant unobservable inputs for which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, the Company records its investments at fair value.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.55in; margin: 0pt 0"><div style="display: inline; background-color: white">The Company’s investments are all classified within Level 2 of the fair value hierarchy. These investments classified within Level 2 of the fair value hierarchy are valued based on matrix pricing compiled by third party pricing vendors, using observable market inputs such as interest rates, yield curves, and credit risk.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"> </div>   <div style=" font-size: 10pt; text-indent: 0.55in; margin: 0pt 0">The fair value hierarchy of the Company’s cash equivalents and investments at fair value is as follows:</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center">Fair Value Measurements at Reporting</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Date Using</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Quoted Prices in</td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Active Markets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant Other</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">for Identical Assets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Observable Inputs</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Unobservable Inputs</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2016</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 1)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 2)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 3)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Cash equivalents:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Money market funds</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">67,001</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">67,001</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Investments:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Bank certificates of deposit</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,500</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,500</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" margin: 0"> </div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center">Fair Value Measurements at Reporting</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Date Using</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Quoted Prices in</td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Active Markets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant Other</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Significant</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">for Identical Assets</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Observable Inputs</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center">Unobservable Inputs</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: left"> </td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 1)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 2)</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level 3)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Cash equivalents:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left">Money market funds</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">61,385</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">61,385</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">-</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Bank certificates of deposit</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">250</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">250</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total cash equivalents</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">61,635</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">61,635</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Investments:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Corporate debt securities</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">2,001</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">2,001</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right">-</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Bank certificates of deposit</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,750</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,750</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total investments</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">27,751</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">27,751</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div></div>

P15Y

P5Y

P16Y

P9Y

6373000

4285000

357000

937000

11952000

7568000

7482000

8339000

86000

-857000

13518000

12453000

24299000

17981000

4903000

8789000

4634000

6646000

-4252000

559000

2932000

2389000

-3169000

3194000

446000

-264000

-45000

-5000

2438000

-496000

396000

-98000

-186000

-459000

17100000

4406000

4700000

1000000

28206000

11259000

11656000

7619000

-7959000

3120000

-3099000

457000

-473000

63000

-125000

49000

24000

121000

48000

4312000

3502000

17264000

14938000

6812000

5780000

6140000

5656000

181000

68000

222738000

235748000

10523000

17278000

22500000

27751000

22500000

2001000

25750000

-23659000

1903000

-4618000

-12902000

6643000

14884000

15510000

11335000

8615000

7819000

2012

2010

13469000

12429000

24178000

17933000

744000

438000

-3000

-536000

420000

238000

-1828000

-536000

417000

238000

-1831000

1173000

781000

25000000

22499000

22018000

9869000

1134000

0.01

1250000

1158000

1385000

27750000

10250000

922000

969000

49198000

40108000

52000

2792000

1812000

4951000

3910000

151172000

135662000

26575000

22898000

48853000

38413000

23304000

19283000

42891000

31255000

1433000

1647000

2751000

3037000

582000

303000

963000

719000

1256000

1665000

2248000

3402000

26581000

22904000

48864000

38424000

21895000

19218000

2977000

2331000

1709000

1355000

39906000

31809000

5542000

4317000

3416000

2298000

6000

11000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-weight: bold;">15.</div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Segment and Geographic Information</div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"></div></div> <div style=" font-size: 10pt; text-indent: 0.55in; margin: 0pt 0">The Company has one reportable operating segment, for the purposes of assessing performance and deciding how to allocate resources.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.55in; margin: 0pt 0">Product revenue by product group is as follows:</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0; color: Red"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended June 30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Orthobiologics</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">23,304</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">19,283</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">42,891</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">31,255</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Surgical</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">1,433</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">1,647</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,751</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">3,037</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Dermal</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">582</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">303</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">963</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">719</td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,256</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,665</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,248</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,402</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 10pt">Product Revenue</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">26,575</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,898</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">48,853</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">38,413</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.55in; margin: 0pt 0">Total revenue by geographic location and as a percentage of overall total revenue for the three-month periods ended June 30, 2016 and 2015 are as follows:</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0; color: Red"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended June 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Geographic Location:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; text-indent: 10pt">United States</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">21,895</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">82</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">19,218</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">84</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Europe</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,977</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">11</td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,331</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">10</td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,709</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,355</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 20pt">Total Revenue</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">26,581</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">22,904</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr> </table> </div> <div style=" margin: 0"> </div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Total</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Percentage of</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Revenue</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Geographic Location:</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; text-indent: 10pt">United States</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">39,906</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">82</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right">31,809</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">83</td> <td style="width: 1%; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Europe</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">5,542</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">11</td> <td style="font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">4,317</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">11</td> <td style="font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,416</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,298</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 20pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">48,864</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">38,424</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.25pt"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr> </table> </div></div>

4255000

3388000

8245000

6993000

1478000

1064000

P4Y

P1Y

P4Y

46300

11805

700000

500000

1500000

1100000

0.4947

0.5161

0.5315

0.5465

0.0094

0.014

0.0115

0.0146

43000

331705

P4Y182D

25000000

7500000

377155

204416000

210848000

432000

375000

432000

398000

15111000

15336000

15210000

15332000

14679000

14961000

14778000

14934000

utr:sqft iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares 0000898437 2015-01-01 2015-06-30 0000898437 anik:RestrictedStockAndRestrictedStockUnitsMember 2015-01-01 2015-06-30 0000898437 anik:DermalMember 2015-01-01 2015-06-30 0000898437 anik:OrthobiologicsMember 2015-01-01 2015-06-30 0000898437 anik:OtherMember 2015-01-01 2015-06-30 0000898437 anik:SurgicalMember 2015-01-01 2015-06-30 0000898437 us-gaap:MaximumMember 2015-01-01 2015-06-30 0000898437 us-gaap:MinimumMember 2015-01-01 2015-06-30 0000898437 us-gaap:EuropeMember 2015-01-01 2015-06-30 0000898437 anik:OtherLocationMember 2015-01-01 2015-06-30 0000898437 country:US 2015-01-01 2015-06-30 0000898437 2015-01-01 2015-12-31 0000898437 us-gaap:DevelopedTechnologyRightsMember 2015-01-01 2015-12-31 0000898437 us-gaap:DistributionRightsMember 2015-01-01 2015-12-31 0000898437 anik:ElevessTradeNameMember 2015-01-01 2015-12-31 0000898437 us-gaap:PatentsMember 2015-01-01 2015-12-31 0000898437 2015-04-01 2015-06-30 0000898437 anik:RestrictedStockAndRestrictedStockUnitsMember 2015-04-01 2015-06-30 0000898437 anik:DermalMember 2015-04-01 2015-06-30 0000898437 anik:OrthobiologicsMember 2015-04-01 2015-06-30 0000898437 anik:OtherMember 2015-04-01 2015-06-30 0000898437 anik:SurgicalMember 2015-04-01 2015-06-30 0000898437 us-gaap:EuropeMember 2015-04-01 2015-06-30 0000898437 anik:OtherLocationMember 2015-04-01 2015-06-30 0000898437 country:US 2015-04-01 2015-06-30 0000898437 anik:EuropeanHeadquartersFacilityMember 2015-10-09 2015-10-09 0000898437 anik:EuropeanHeadquartersFacilityMember 2015-10-09 2016-03-31 0000898437 2016-01-01 2016-06-30 0000898437 us-gaap:EmployeeStockOptionMember anik:PlanMember 2016-01-01 2016-06-30 0000898437 anik:RestrictedStockAndRestrictedStockUnitsMember 2016-01-01 2016-06-30 0000898437 us-gaap:RestrictedStockMember anik:PlanMember 2016-01-01 2016-06-30 0000898437 us-gaap:RestrictedStockUnitsRSUMember anik:PlanMember 2016-01-01 2016-06-30 0000898437 us-gaap:RestrictedStockUnitsRSUMember anik:PlanMember anik:BoardOfDirectorsMember 2016-01-01 2016-06-30 0000898437 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember us-gaap:EarliestTaxYearMember 2016-01-01 2016-06-30 0000898437 us-gaap:ForeignCountryMember us-gaap:MinistryOfEconomicAffairsAndFinanceItalyMember us-gaap:EarliestTaxYearMember 2016-01-01 2016-06-30 0000898437 anik:DermalMember 2016-01-01 2016-06-30 0000898437 anik:OrthobiologicsMember 2016-01-01 2016-06-30 0000898437 anik:OtherMember 2016-01-01 2016-06-30 0000898437 anik:SurgicalMember 2016-01-01 2016-06-30 0000898437 us-gaap:MaximumMember 2016-01-01 2016-06-30 0000898437 us-gaap:MinimumMember 2016-01-01 2016-06-30 0000898437 us-gaap:EuropeMember 2016-01-01 2016-06-30 0000898437 anik:OtherLocationMember 2016-01-01 2016-06-30 0000898437 country:US 2016-01-01 2016-06-30 0000898437 anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember 2016-02-26 2016-02-26 0000898437 anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember 2016-02-29 2016-02-29 0000898437 anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember us-gaap:CommonStockMember 2016-02-29 2016-02-29 0000898437 2016-04-01 2016-06-30 0000898437 us-gaap:EmployeeStockOptionMember anik:PlanMember 2016-04-01 2016-06-30 0000898437 anik:RestrictedStockAndRestrictedStockUnitsMember 2016-04-01 2016-06-30 0000898437 anik:DermalMember 2016-04-01 2016-06-30 0000898437 anik:OrthobiologicsMember 2016-04-01 2016-06-30 0000898437 anik:OtherMember 2016-04-01 2016-06-30 0000898437 anik:SurgicalMember 2016-04-01 2016-06-30 0000898437 us-gaap:EuropeMember 2016-04-01 2016-06-30 0000898437 anik:OtherLocationMember 2016-04-01 2016-06-30 0000898437 country:US 2016-04-01 2016-06-30 0000898437 anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember 2016-06-30 2016-06-30 0000898437 2014-12-31 0000898437 2015-06-30 0000898437 anik:EuropeanHeadquartersFacilityMember 2015-10-09 0000898437 2015-12-31 0000898437 us-gaap:CertificatesOfDepositMember 2015-12-31 0000898437 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel2Member 2015-12-31 0000898437 us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0000898437 us-gaap:MoneyMarketFundsMember 2015-12-31 0000898437 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2015-12-31 0000898437 us-gaap:FairValueInputsLevel2Member 2015-12-31 0000898437 us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0000898437 anik:ElevessTradeNameMember 2015-12-31 0000898437 us-gaap:InProcessResearchAndDevelopmentMember 2015-12-31 0000898437 us-gaap:PatentsMember 2015-12-31 0000898437 us-gaap:CertificatesOfDepositMember 2015-12-31 0000898437 us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0000898437 anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember us-gaap:CommonStockMember 2016-02-26 0000898437 anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember us-gaap:CommonStockMember 2016-02-29 0000898437 2016-06-30 0000898437 us-gaap:AdditionalPaidInCapitalMember anik:MorganStanleyCoLLCMember anik:AcceleratedStockRepurchaseMember 2016-06-30 0000898437 us-gaap:CertificatesOfDepositMember 2016-06-30 0000898437 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel2Member 2016-06-30 0000898437 us-gaap:MoneyMarketFundsMember 2016-06-30 0000898437 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2016-06-30 0000898437 us-gaap:DevelopedTechnologyRightsMember 2016-06-30 0000898437 us-gaap:DistributionRightsMember 2016-06-30 0000898437 anik:ElevessTradeNameMember 2016-06-30 0000898437 us-gaap:InProcessResearchAndDevelopmentMember 2016-06-30 0000898437 us-gaap:PatentsMember 2016-06-30 0000898437 us-gaap:CertificatesOfDepositMember 2016-06-30 0000898437 anik:EuropeanHeadquartersFacilityMember 2016-06-30 0000898437 2016-07-28

EX-101.SCH 7 anik-20160630.xsd XBRL SCHEMA FILE 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1 - Nature of Business link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 3 - Recent Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4 - Investments link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 6 - Equity Incentive Plan link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 8 - Inventories link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 9 - Intangible Assets link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 10 - Goodwill link:calculationLink link:definitionLink link:presentationLink 015 - Document - Note 11 - Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 12 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 13 - Leases link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 14 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 15 - Segment and Geographic Information link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 5 - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 6 - Equity Incentive Plan (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 8 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 9 - Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 10 - Goodwill (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 11 - Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 15 - Segment and Geographic Information (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 1 - Nature of Business (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 4 - Investments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 5 - Fair Value of Financial Instruments (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 6 - Equity Incentive Plan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 6 - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 8 - Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 9 - Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 9 - Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 10 - Changes in the Carrying Value of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 11 - Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 13 - Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 14 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 15 - Segment and Geographic Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 15 - Product Revenue by Product Group (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 15 - Product Revenue by Geographic Location (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 anik-20160630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 anik-20160630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 anik-20160630_lab.xml XBRL LABEL FILE Document And Entity Information Research & development Note To Financial Statement Details Textual Tax Period [Domain] statementnote5fairvaluemeasurementstables Operating expenses: Tax Period [Axis] statementnote6equityincentiveplantables statementnote7earningspershareepstables statementnote8inventoriestables statementnote9intangibleassetstables statementnote10goodwilltables Amendment Flag us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements statementnote11accruedexpensestables statementnote15segmentandgeographicinformationtables statementnote5fairvalueoffinancialinstrumentsdetails statementnote6assumptionsusedtoestimatefairvalueofstockoptionsandstockappreciationrightsawardsdetails statementnote7basicanddilutedearningspersharedetails statementnote8inventoriesdetails statementnote9intangibleassetsdetails Non-cash Investing Activities: statementnote10changesinthecarryingvalueofgoodwilldetails statementnote15productrevenuebyproductgroupdetails statementnote11accruedexpensesdetails Notes To Financial Statements Document Fiscal Year Focus Changes in operating assets and liabilities: statementnote15productrevenuebygeographiclocationdetails Document Fiscal Period Focus Notes To Financial Statements [Abstract] New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Document Period End Date Provision for doubtful accounts Selling, general & administrative Current Fiscal Year End Date us-gaap_CashAndCashEquivalentsFairValueDisclosure Cash equivalents us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent Document Information [Line Items] Document Information [Table] anik_AccumulatedCurrencyTranslationAdjustment Accumulated Currency Translation Adjustment Represents the amount of the accumulated currency translation adjustment. Entity Current Reporting Status Purchases of property and equipment included in accounts payable and accrued expenses anik_LesseeLeasingArrangementsNumberOfRenewalTerms Lessee Leasing Arrangements, Number of Renewal Terms Represents the number of renewal terms of a leasing arrangement. Entity Voluntary Filers European Headquarters Facility [Member] A build-to-suit lease agreement for a new European headquarters facility, consisting of approximately 25,000 square feet of general office, research and development, training, and warehousing space located in Padova, Italy. Entity Filer Category Document Type us-gaap_DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance Other comprehensive income (loss): Unrealized gain (loss) on securities, net of tax Common stock, shares outstanding (in shares) Cash and Cash Equivalents Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Expected dividend yield Cash flows from financing activities: Interest income, net anik_LesseeLeasingArrangementsTermOfContract Lessee Leasing Arrangements, Term of Contract Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities anik_LesseeLeasingArrangementsRenewalTerm Lessee Leasing Arrangements, Renewal Term Term of the lessee's leasing arrangement renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. us-gaap_StockholdersEquity Total stockholders’ equity Entity Well-known Seasoned Issuer us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income before income taxes Certificates of Deposit [Member] Geographical [Axis] us-gaap_ComprehensiveIncomeNetOfTax Comprehensive income Geographical [Domain] Statement of Financial Position [Abstract] Money Market Funds [Member] Long-term deposits and other Represents deposits and other assets, noncurrent. Europe [Member] Preferred stock, shares outstanding (in shares) us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets us-gaap_DepreciationAndAmortization Depreciation and amortization Prepaid expenses and other current assets us-gaap_IncreaseDecreaseInInventories Inventories us-gaap_TableTextBlock Notes Tables Statement [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets by Major Class [Table Text Block] Tabular disclosure of finite-lived and indefinite-lived intangible assets by major class. Plan [Member] Represents the Anika Therapeutics, Inc. Second Amended and Restated Stock Option and Incentive Plan, as amended, (the “Plan”) Income Statement [Abstract] us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Total other comprehensive income (loss) us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Statement of Cash Flows [Abstract] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses, other current and long-term assets Long-term deferred revenue anik_AccruedClinicalTrialCostsCurrent Clinical trial costs Represents accrued clinical trial costs current. us-gaap_EarningsPerShareDiluted Net income (in dollars per share) us-gaap_EarningsPerShareBasic Net income (in dollars per share) anik_AccruedResearchGrantsCurrent Research grants Represents accrued research grants current. Diluted net income per share: anik_StockRepurchaseProgramPercentageRepurchased Stock Repurchase Program, Percentage Repurchased The percentage of shares repurchased under the stock repurchase program. Basic weighted average common shares outstanding (in shares) Shares used in the calculation of basic earnings per share (in shares) us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment Stock options, SARs, and RSAs (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Diluted weighted average common shares outstanding (in shares) Diluted shares used in the calculation of earnings per share (in shares) Maximum [Member] Minimum [Member] Range [Axis] Range [Domain] Deferred tax liability Licensing, milestone and contract revenue anik_NumberOfProductsDevelopedManufacturedAndCommercialized Number of Products Developed, Manufactured, and Commercialized Represents the number of products the Company has developed, manufactured, and commercialized throughout the course of its existence. Fair Value, Inputs, Level 2 [Member] us-gaap_AvailableForSaleSecurities Available-for-sale Securities Basic net income per share: Retained earnings Accumulated other comprehensive loss us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders’ Equity Fair Value, Hierarchy [Axis] us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Accrued expenses and other current liabilities Fair Value Hierarchy [Domain] us-gaap_SalesRevenueNet Total revenue Total Revenue Schedule of Accrued Liabilities [Table Text Block] Products and Services [Axis] Products and Services [Domain] Investments Investments Legal Entity [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Entity Registrant Name Income Tax Authority, Name [Axis] Entity Central Index Key Income Tax Authority, Name [Domain] Entity [Domain] Internal Revenue Service (IRS) [Member] us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Ministry of Economic Affairs and Finance, Italy [Member] Elevess Trade Name [Member] Represents Elevess trade name. Orthobiologics [Member] Represents Orthobiologics. Entity Common Stock, Shares Outstanding (in shares) Board of Directors [Member] Represents the Board of Directors. Domestic Tax Authority [Member] Income Tax Authority [Domain] Foreign Tax Authority [Member] Surgical [Member] Represents Surgical. us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities Other long-term liabilities Income Tax Authority [Axis] Dermal [Member] Represents Dermal. Segment Reporting Disclosure [Text Block] Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Trading Symbol us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable Income taxes payable Other long-term liabilities us-gaap_OpenTaxYear Open Tax Year us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax Earliest Tax Year [Member] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Investment Type [Axis] Investments [Domain] anik_BuildToSuitLeaseAgreementOffsettingFacilityLeaseObligation Build-to-suit Lease Agreement, Offsetting Facility Lease Obligation Represents the amount of the offsetting facility lease obligation under a build-to-suit lease agreement. us-gaap_StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares Fair Value, Assets Measured on Recurring Basis [Table Text Block] UNITED STATES Name of Property [Domain] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Name of Property [Axis] Common Stock [Member] Current assets: Equity Component [Domain] Equity Components [Axis] us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Increase (decrease) in cash and cash equivalents us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents Exchange rate impact on cash Additional Paid-in Capital [Member] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Provision for income taxes Income Tax Expense (Benefit) Accounts receivable, net of reserves of $220 and $167 at June 30, 2016 and December 31, 2015, respectively Nature of Operations [Text Block] Class of Stock [Axis] Accounts receivable, net of reserves us-gaap_EmployeeRelatedLiabilitiesCurrent Compensation and related expenses Commitments and Contingencies Disclosure [Text Block] Income taxes payable Accounts payable us-gaap_AccruedLiabilitiesCurrent Total Accrued expenses and other current liabilities Other Location [Member] Represents other location. Common stock, par value (in dollars per share) Schedule of Revenue and Operating Income by Geographical Areas [Table Text Block] Represents schedule of revenue and operating income, by geographical areas. anik_PercentageOfNetRevenue Percentage of Revenue Represents the percentage of net revenue. Product revenue Product revenue us-gaap_OtherAccruedLiabilitiesCurrent Other Preferred stock, shares issued (in shares) us-gaap_AccruedProfessionalFeesCurrent Professional fees Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively Preferred stock, par value (in dollars per share) Preferred stock, shares authorized (in shares) us-gaap_AreaOfRealEstateProperty Area of Real Estate Property us-gaap_OperatingIncomeLoss Income from operations Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] us-gaap_LiabilitiesCurrent Total current liabilities EX-101.PRE 11 anik-20160630_pre.xml XBRL PRESENTATION FILE GRAPHIC 12 exh3_1.jpg GRAPHIC begin 644 exh3_1.jpg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end GRAPHIC 13 exh3_2.jpg GRAPHIC begin 644 exh3_2.jpg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
A6LZSV]G'',E>+BM144/?PQ5,@ .F*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5_]?U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5?_0]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_ MT?5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]+U3BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_3]4XJ[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%7_U/5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5_]7U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5?_6]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_U_5. M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]#U3BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_1]4XJ[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%7_TO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5_]/U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5?_4]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_U?5.*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_];U3BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_7]4XJ[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%7_T/5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5_]'U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_2 M]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_T_5.*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]3U3BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5?_5]4XJ[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%7_UO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5_]?U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_0]4XJ M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_T?5.*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]+U3BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5?_3]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%7_U/5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 M_]7U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_6]4XJ[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_U_5.*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]#U3BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5?_1]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%7_TO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]/U M3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_4]4XJ[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%7_U?5.*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_];U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5?_7]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%7_T/5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]'U3BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_2]4XJ[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%7_T_5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5_]3U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5?_5]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_ MUO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]?U3BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_0]4XJ[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%7_T?5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5_]+U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5?_3]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_U/5. M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7U3BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_6]4XJ[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%7_U_5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5_]#U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5?_1]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_TO5.*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]/U3BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_4]4XJ[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%7_U?5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5_];U3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_7 M]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_T/5.*NQ5V*NQ M5V*NQ53N)O2A=Z%BJE@J@L20*T &Y/MBK";/\PM3EM%]?1Y(=2N[]M/TJS:1 M*3,HK\.*L@TYO-'UZ-;V>QGMC$[7 MTDC>*;DO MIJO*23U(^)DYLPB;X4^'XOA50D>L:W<>>9](M9+8Z386<5Q?EHW:<3W#,(H5 MD$@3[$;2ORCY*OI_[\Q5D,TR06[S3.L<<:EY)&-%55%223V Q5C=MJ7FW5]( MCU;2!9VL-RJS6%O>))*\L+,"KRO&\?HF2+XE0)+Z?+X_Y<5=Y0\UP:E%=?6M M0@>=IKJXM+?X8Y4TZ.8QQ22)R/PD#GZA"?!)'S^+%45)Y\\GQQQR-JL!2:X- MG&5):LRKS930;!%WD<_!'^VV*JY\TZ(=4DTU;I3<06XNYC_NM8F^R3)]FK#X MN-?L?%BJZ+S9Y8ED@BBU6T>2Y*"W19D+2&2O (*U8MP;8?RXJAO,6OWFF7>C MVMM!'<2:M>K:?&[(43@TTD@4*0_"**0\>28JE\GF[4KCS6FA645M J.WJ_7V MN(+B>*/CZDEF@B,4R+\2_P!]^SRX^GQYJJ^E^:FUN>>;2Y[9-(LV=9[J9NE^9-4^KS:?J,L"/#!#) M!-%%>SB&UE'J2RJY/JP--'\'%6?TY'X?&JR^^U33].MQ-J%S':Q%@@DF8(O( M[ 5)IBK'K'S3=-JM]]9GMETTZD;"P$KBWDXVUMZETR\BWU@K.LB<0(N*)(_V M4^)5-6\X>55MOK3:M:BV]);@S&5 GI.>*ORK3B2<5:_Q-ID6I7-G=W=I!Z4D M$$/*Y3U7EG7D(VB(5HW_ )%JWJ+\7PXJNF\V^68=,&JR:G;C327478D!C+1$ MK( PK4HRLK?RXJ[_ !/HXUBYTMK@+=6<(N+D$$*B-T!;ISI1N/\ (R_S8JKZ M;K^B:F7&G7T%X8U5W$+J]%>O$FA[E6'^LK+BK'?,'G>W].XM-&O$34H+ZUL9 M))8^42-(X>R*35NF*H=?,_EQ MH_474[4IZZ6H;UDH9Y*<(AO]M^:\5_:Y8JU_BGRWZ,4_Z4M?1FG-K#)ZJ4>< M2"(Q*:_$XD(3C_-BJEJ?G+ROIDCQ7NI0Q3QM&C0:-%;5[32XKI)KF\A:XA$7QH8UZ-S7X1S^+A_/P?^3%41=:YI%M:?+]QI*ZO'?1?H]@K&9CPX\U# .K49&XL M#P=>6*M6_FORU"-K6+U%#R"6/U8^"$\FY1CF-OLXJK2:_HD5R M]K)?0)Y8I I%:AIG!6,?MMBJ4>9/.6GVVDZPNE7<4^LV$ ]. MW0>J5GG8PVP905KSN/@^VO[6*II::WIE?JTN"6] MALM/].YNM5EN.*H((E5(QS8KP6-Y%5EC0 LY!/10RG_9+BJ[]/:+6$?7H*W'H^@/46K_ %@,8>.^_J\']/\ MGXMBJE_BGRV9S;_I.V]<,\9B]5.7*.,RN*5K\,0]3_4^+%72^:/+D2QM)J=L MBS0BYB+2H \) (D7?=*,N^*HJRU;3+^W>YLKN*YMXW>-YHG5T#QFCJ64E:H? MM8JIZ;KFDZHDSZ==)=);R>A,T9Y!9 JN5)\>+HW^RQ50_P 6>6/1:?\ 2MKZ M*2_5WD]9.(E 5BE:TY<71O\ 596Q53N_.?E2S67?J$5^VHP1VDQ CED=4'(T/$\J%66OQJWQ)^WBJX M>9O+QN9+8:E;&YB61Y(!*A=5@($I*UJ!&67E_K8JA/\ &OEJ233XX+])CJ4L ML5JT=64M;\A*68"BJCKZ18_[M9$_:Q5?8>:=*EM+*>ZO;2"2_)%LB7*2I(>9 M4>G(.'J5IV7[?P8JB;7S'H%W/%;VNHV\\]P)6@CCE1V<6[<)BH!/+TW^%Z8J MZX\Q:#;SS6\^H01SP!&FB:10Z"4D(66M1S(/'%6G\S>7TL[B];4;<6EI*T%S M/ZBE(Y4%61B#LR@\B/Y<5:A\S^7IGC2+4;=I)/0X1B1>9^M*7@'&O(&949HQ M^UQQ5K4_-/EW2UN3?ZA#;M:1&>>-F'J",=P@J[>RJO+[/\V*JC>8M#73/TH] M]"FG][IG 0>(8G[)7]L-]C]K%4-J'FK2(+6^>VO;2:YT\(;B*2Y2%$,C%4$D MA#B/FRLJU7[2\<52.7SW877F>[TJUUBSLXM(59+[U]Y)3'^\N8TY%0J6]O1I M9%Y<))%Y<51O459%JGF/1=(L$O=1NT@MY&1(GW8NTK!4"*H+/4L/LK_E?9Q5 MN\\RZ!9P6\]S?P1PW3*EM)S!$C.P50A%>7)F513]K%5]IY@T.\NGM+2_@N+J M-6>2"*17D54?TV9E!) #_#BJV#S'H$[\(-1MY'K,.*RJ?]Y2HGZ'_=/-/4_D MYKBJ3:KYO@N/T6F@WT$IN=1%O=S$[!)9 C+$O#G^Q(Z_#BJ>6>NZ M+>Q"6TOH+B,Q?6 \4BNIAJ5]0$'^[Y(R\_L_"V*K7UJP?2)M3M;B&:UB21_7 M,JI#6*H8/+NL85E*N6_N\50\'FSR^T<0FU*TCN7-O')"MPC\9KH?NHP13DTA M_N_A7U/Y<51.L:M%IU@]QQ]6K'X47D[?"N*I-Y?\ M]:7=>5M(U;6;NUTVZU.SBO&@DF"(OJA:A#(5+*'<(O\ -BJ(3SCI<]PT%G<0 MR217Z:=.)I?0_>%>3"'DI]=U(9/33[3I*O+]WBJCK?FA9&L[/0+R">_FU*WL MIPG&<1I3U[@. R\6^JQR<37[7[+8JGEGJFFWK3):7,4[6[^E.L;!BCT!XL!T M-#7%6#77G/S5^A-:U.T>RDXZG^BO+<36\H^L2"=;8^J1/\2^N94Y1?[KA:7C M_NI54[T/5O,-YYIU.PFFM9=+TJ.WBFFC@DCD>]EC]62-6,TB!(HVA?[//][P M_9YNJK^:?,,^DW&EP(\=NFJ77U/Z_<+S@A=HF>,,H>,EYY%$,7QJO-OYN"LJ MC[35! EC::Q<6\6KW0($$;$+(Z@LPB5SR^RI;C\7[7VN.*ND\R:&FF7VI"\C MDL]-61KV2-@_I^BG-P0O[7#X@/VOAQ5)[74O.5]:0ZC%'96"77H26VEW@D-P M(792_KRJRK%-Z;?W20S*DB\/4?%41YRUG5]/32K;1V@_2.IWT=I&ES&\J>GQ M:2>2B21,/1@CDD_:^)53X>?-560H&"*'(9Z#DP% 3W(%33%4B_3.H:AJU[IN MD>BB::4CO;Z8&51,ZB3T4B5H^3+&R-([2JJ<^/QMRX*I6?,VIZ=KMC9:]?V- MK%';3S:FX'IPN9+@0V'IM*Y9))%65I$_>+\/^KBK()/,F@1WLMC)?P)=P1-/ M/$S@%(D*JSM790K2(-_YL50#>??*QTBWU>*^62QN)(XHF16+EYC\(,9 D7X? MWGQ+_=?O/LXJCY_,WEZWN)+>?4;>&>+AZL8[GS/=Z1975GZ.GV=M-=/);RDFY MN&<+'R6;BJLD7J=&>-9(_P"\Q5-O+&N?IO1H[]H3;R^I/;W$)(8+/:S/;S!6 M%.2>K$_!J+R3]E?LXJFN*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5__1]4XJ[%78J[%78J[%7$ ]<5277=!DO;O3=0M'2+4-+DDDMVE! M:)EFB:*2-U4J?B5JAU^PRXJE^B^5M2T[5+[5_5M3J&K7:2Z@R0,JBUAA]-(( MB7KSYA97F?[7*1>']WQ54;;R_P"<[235YK6\T^*\U6Z-R]V89G9$6-(HHPC/ MQ;A'$HK55^TW#DV*LDN[!;_1YM/OZ2K=V[6]WPJ@82)PDX[DK6IIOBJ0/H/G M Z1'I,&K6]I#!;FVCNXK=FF<^D8HV=7?@G GU6]/[3HOQ(G+%4ND_+;T5A33 MI8+6WMEM;.&W>)I$73[5S*T?VDY2SS^E).Y^&584C?%4ETGRU=:G>2:$=8M[ MD:-#/;ZS.03?N%$,FSK'(\/V%Y-BJ;Z'Y/T_3M3O=0,,/.80 MPV,21A5MK:%05CC'[):8RS2,OVF9/]]KBJV^T'5[CS?8ZR9(&T[3;:XBMK,* MXF,USPY2&3EP^S'Z:IP_;Y_:Q53N]"U;7+VUGU-$L;*Q$KVEO"YDN/7G@>V, MCR46-!'%-+PC02&*I+_RKO75TL6\6H6T-W;Z2="LYXXI$7ZN_ 23 M2A7#M.5B3TN+JD#>JW^[,53MO*][?7&F#4IXH]-TN1)H-*LXRL4DD(I TSR$ MN4@/QQQ(J+ZJH[L_'CBKM7\H/J7F5-3N6BN[&.W6&*PN!(R1RJ[NTG!76*7U M28>7JJW#T/@^UBJ3V_Y=:NMMID4VIPM)IUI>1>L+7YK)=#D_'X27<274UW<7D,LKWUUJ:QF \#/)%Z%HLA+EFA@BX^HB\/6=%_RN:J B_+#6 MTBLH&U2W:WM5LTD06Q_>""5KBYJ"[+_I-UZ4[_#\?I<'^'%4TU#R1K%\")]2 M$L?HL\DYDNGG:/UO5E_R%Q55UOR=JVI3:Z4OXX4U>"&W@D,1::!(EWB#AP/ M2=S*[$+ZG[]_B^!,54(ORZ^"V,TL!=+HWUS$D 2%I(K<6]I @5@R6ELB)\'+ MG+Z:_$J\EQ5WEOR'JVD,C2WUO<-]3^KO)]6^)+AY9)YIHP7X_OYY(Y9.:M_< M(GV?[M5(-.\KR)K%GH%C?V?Z9T>W^N:MJ)62>Y>6:-X+:0B28N75VN+MHG_< M)*\/P_9=E69^6/*C: UQ%!/RT_A!;Z?: $>C;V\0159F+%W+^K(>/!?WGV<5 M8SJ_E^ZTB^OM5EO$NM2N)[J[T.V$)]66^EA-O;++)4CA9POZ,"IZ?[MY)&_: MQ5&>8[6WL?+.D>1[2Z@AN]22+3XEF:G*"%.=R]%,;GU$C:+DGQ>I-RXXJI:M M^6NKW:7/H:I%')?+2- U6GNC'"[* Y5$6PB%C']IXX_B^T[8JR/0_*L-C MJ-_J5UZ=Q>W;1+#((PHAMX(ECCBC&_ <@\C0 MP3WY233'$3'T)8H/3BDE^/\ >&&4R3Q\/3^.3DW)D3%4'9_EWJL$\9;4+=H$ MO[:Z],6Y%+:Q@].UMU)<[0R4E7ER^/\ >?;;%4-J7Y7ZU>7KWL>M)9W+7&H7 M2206Q'"6[B%O;R9_3B$G/U?YEX8JI:OY$&K:IJ%Y>S+(FI+;VDBE"&CTZ M#]Y);(0=S=3-+ZS_ .^9/3_8Q5*O^58ZBUGJ"SZA!/?3I=QVD\D!IROY0T\\ M]&YF=H$BM8_2>-88H_A^U\"J(NOR]U6YBUI7U-%FU"4SV5S'$RO"WU=;= ?C MV6&,2+#Z7!T]7U.7JISQ5$1?E]%'=:?) EK:V\,%Q'J$<,XX*"LTCLQ MXPJ\'*7F_"3]WZ>*H6+\LJV%Y:W,L4DEY<5>]59!-]2:?U)+9 SM' &@"6E( M%1/23E_+Q59%K_EZ2_T>/3=/:&RA,T!N8_2K&]O&ZL\(5"E/450G^I\&*I=9 M>4=9M_)U_HK:DHU2^^LO+JD<(7]]=.SM(4KO]KQ^'[*?8Q5!W_Y>W-_J,4EQ M/;+I[6L-E4/[V22:X:XO#%\31QK?4@@G4J_&VMUC3[7-543/Y#U/ZO&UK>P1 M:C+?SZC?WDD!D,DK!_JP0VL%M(@T7&9II']2Z MG=PQ6L[+%\"+\"Q\%^'[2KM5_+^+5+V]GN9SZ>I3PF\1!P/U.W6OU:-EW'KS M#G2'^7%4EE_++S"]B8)-6M1ZL<_UHI:LH:2\N1+=D 2?9EMP+9=N< M/]XS?[[7%4 MFUO3[J3S)^B%O;-;[6KB+4)K4^IQ-GIC AG0R\O6F_T6"7T_W[]-7$4C2M\/HSJ\4:?9^TZLJW>^5 M)++REI6GZC?VMO;Z=JZ/*CP6O&,.G)D9I)Z..')(>7VDQ5#6WY;7EG?V7U2] MB32+">W:WL6B+N8+2 B&-W9B"R7;RW?(+_>29N'IXJHVGY>^88+0*VJV\EXFG7EK'>2P468CDAC^IZ?$%2TY M)*7CA]3E(%A*\O\ =WJ\Y'Q5DNM^4H[SRE)Y>T\PV$$X2.?C&Q3TC('N %#J MW.5>?Q&3ER?FSK M(QY>I/\ O/V57%4RF\O7U[JUS>ZHMI>V\<1CT>SDB+)"S5]223D&Y/)\",R_ M81>*?;?DJEGEKR!=:9;Z8E_/!>RZ-I8TW3AZ1]%9*GU+AD8D\Y%6)-F^!/55 M6_>XJZX\AZW+9:/;C6 D^EV]T!>>B6]MM.^JZ9/I]L;6!P8Y)^",3\N1XT:5YN+>IRE?E^PF*IIY4\O:_H\ 2[NK6>:Y MO;N]U6>.*13,;@EHQ'R<^EZ54C_;_=1)]G%53S-Y;O\ 6HK_ $^2>*31M4MA M:W-K-'R:+[8>6%@>/J,'3CZB_NWA1\522[_+:[N5UJ]U>$"POI!*T\$05 M(S"/W@2.L"20^O J3_OGEY>I]I5/?\&Z7+Y5O- D@CMX=1ADBO&M^0Y-*O$O MRD+N[+L%:1F^S_+\.*H*Z\J:S?ZQI^J:C<6&9XTCD>,!U63D(^:H_'B_\R8J@+[\OI;R MZO[J>[2>XU":!YII8@6^KV2J;6VHI53']85I[G[/K MUG2?4Y^,CR7IA0^F)7F:1N!N&^M21_W?/X57[;,JG'G7R[J&M:$VD:=);VT- MP\8O/61V#0+(LCQH(RO RA3'S_8Y7O-D+ZLXU"U@N-5N&G-]%#))-"GIK%$D:2OZ=8 MHT^%F_=\_P!YZ+ MO7D]E'HTUL)6*\DDMK@-QEMYF9W5FA-4D/&%EE7APQ5-Y_,WE^$D/J5J&6W: M\9?50GZNH5FFH"3Z05T//[/Q+BJ'T[S9IE\T$D,\"V<]E]>]2658YD3F$^.! M@'1.O*1C\+_N\51)\T^6A$)CJMH(C$]P',\8'HQ'C))U^Q&WPNW[+?#BJ[6- M?TS2=&EU>ZEK91JK*T=',AD(6-8Z'XFD9E5/];%5+1K_ %.]MC>7*V\<,XY6 ML%N_K,%W_O)@?29NQ$8X(W^[9,50-AK.HGS(^CWEC%"[V?UY)[=VD" 2^F(I MR43XY"6:+C\+^G-_)\2J)\H>8)]>TEM1F@2W1KFXAMUC:(QVU]<12(L(N^"ET'Q-Q^)N2IR^RRXJC[[5=,L M%C:^NX;59G6*(S.L?-W8*JKR(JQ9E6F*J$_F3R_;M<+/J5K$UH ;H/,BF,,W M$HZ $_:5/C8?RXJI'S9Y8 M%M]:.K6@MA$L_KF>,)Z3GBK\JTXEMN6*JM]YAT&PE>*^U&VM98X_5D2:9(RL M8H.1Y$?#N,50^I^;_+NGV5S>37T31VDRVLXB82.MP]"L15*GU"&5N'\OQ8JC M;'5M-O89)K6[AN(X6*321.K*C* Q#$';X2&_U<50P\U>66AEF35K-HH!&9I! M/&503 F/F0WP\PK%>7[.*I9I_FV*.'6=3UJ\M[/2+>^EMM.FD B'IVR*DQ9B M[<_](2?XJ)\"_9_:Q5$7?G'28FU6"*YA>\TFW6XN(YI!!$O-2RJ\S#C'T4O7 M^[62-_V\53"UU_1+J188+^WEG9Y(Q%'*C,9(55I5 !W,:NK/_*K+BJZ/6=+F MM)KR"\AEMKM+GUC2[FWOK>VT:>TFNKZ MXN5$1/*1(;90[E"CO()?A(;X(_V?AQ5D]SKNBVMPUO=7]O!.H5FBDE16 =@B MFA(.[,J_[)?YL50\WFCRRELMTVJVH@D65XY1,A1U@Y>J5()Y>GP?GQ_D?^7% M5NG>8?+VH1V$D=U#ZU_&);*&0JDS @M01M\884;DO^2_\N*IQBKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL56M#$SAV4%UZ,0*CZ<578J[%78J[%78J[%7'<4 MQ5H*!7WZXJM]"/ERX@N.C4%?O^G%5^*N(KBK00 UW]L5:]*+U/4"CG_-05^_ M%5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ58\, M3FKJ&(Z5 .*KP !3%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%7_T_5.*NQ5V*NQ5V*NQ5 ZQ;W\]KPL+@6UT&C= M)73U$(CD5VC=:CX94#1,1\2\^2XJP^;\NII]6;4I9HO2O;AKK5=*C,T=K)+Z M20I*OILC/((UD]19?@F>7D_]U\2J)C\E:G%I%YIL-S:PFYO/6%S';LKBU:8, MT) <*"+5(K-%7]UZ<7Q*W]VBJCKGD/5M1U:[U(7T#^M-9,EI<0NT%W13_NE?L_%R;%62>8O+T^HVNFBVDCCGTN[AO84D0^A(859/3=%W5:2%DX_ MW6AN;YI+I1)#((8KR=RTA1%>OU=%]/A%\+M) MZLDDG[SX55>#1_,EOI6I"WGM$UB\7]W>,DDB^KQ*^M+7B7XCCZ<*A(T5."_Y M*K7E[2M;T>'1-(3T?T1IVG?5KM@K%GGC]-(3$S-RIQ65I1(G[2?'BJ#\S>3M M;UG5S<+?PQ6'&UB^K21-(WHQS&>Y0DMQXW#);\OA^)8?3^RV*I;J/Y:ZO,YF MLM4AMKR26[O)+KZL2RW,Z^E;F$!P(UMH"Z*?M^KQN/MKBJ=>5/)TNA:I>7@E MA]">"WMK>VBC<>DD 9N(9G/PF261J\?4E9O4F=WQ53OO)NH:E]934+U)K2[U M-+^>U$9"O!;+_HUN6)9@!+'!)*1\#>FRHB^J[8J@]/\ RX$>MF^OWAOK6>LM MS:2"41K7F@WTOF-]1^L1-:M9K:Q12 M1%Y('YN[R1$L$_>MZ#/R5O\ >9/YO@58YIOY7NME#;ZG=QS2*+>*:2"(H6@@ MF:YG^-B9!-?W;&:[DY?9^!/]^.JW_P JVOCJ'UWZ]")I/K"065LOIPQ:GP=[B:#UC.\2%W*VIE M811.MN%584XK_NOTU41IODW7;'T)$OK594O+O4;A8[=U2269/3M4X\_[N&+X M&_:X*GI\'7U,53?2M OM.\K2Z=#/&E\4G^KRT9XHGF+,BJ).3M%$6HBOR^!> M&*I(?RVACN+%(/1ETRRL?JJVERLA5[CD7:YE6-D6Y:=N'JB?E_NSC_>OBJ#' MY;:[]6LK1]3MFL[:&T@EB^KL>:QSFXNQNW$_6I5A9SQ5G]+BW'EBJ:WGDW5K MW09]+N[^*62]U$7M[(8G*& 3B40(O,/]A(X>32?8^SQQ5#/Y OWT.XM'O(EU M*::9DGA22*,0W-V)YXP0YEC:XA5;9Y(W_=)_3E]G%4!=^01>ZA>7=_.ER+^6V%P6CXN+&RXM% M:+3X0LLWJR7+?[L25HN''%4):_EHSZ>MMJI/;7+1R,T%MR7G!'%S M$$;>BK0\T7]ZLDK3?WDBNJJ+Y&UA=7O-5^OP2W7UF:^T]YH"Y]=XC;P?6*%> M4=G \D<"0^GR]1I&Q5G$8(!&*KL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_U/5.*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7U3BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK ML5=BKL5=BKL5=BKL5?_6]4XJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%7_U_5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]#U M3BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_1]4XJ[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%7_TO5.*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V 4*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]D! end GRAPHIC 14 exh3_3.jpg GRAPHIC begin 644 exh3_3.jpg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end GRAPHIC 15 exh3_4.jpg GRAPHIC begin 644 exh3_4.jpg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htm IDEA: XBRL DOCUMENT v3.5.0.2

Document And Entity Information - shares
6 Months Ended

Jun. 30, 2016

Jul. 28, 2016

Document Information [Line Items]

Entity Registrant Name Anika Therapeutics, Inc.

Entity Central Index Key 0000898437

Trading Symbol anik

Current Fiscal Year End Date --12-31

Entity Filer Category Accelerated Filer

Entity Current Reporting Status Yes

Entity Voluntary Filers No

Entity Well-known Seasoned Issuer No

Entity Common Stock, Shares Outstanding (in shares) 14,777,663

Document Type 10-Q

Document Period End Date Jun. 30, 2016

Document Fiscal Year Focus 2016

Document Fiscal Period Focus Q2

Amendment Flag false

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 17 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands

Jun. 30, 2016

Dec. 31, 2015

Current assets:

Cash and cash equivalents $ 89,125 $ 110,707

Investments 22,500 27,751

Accounts receivable, net of reserves of $220 and $167 at June 30, 2016 and December 31, 2015, respectively 24,597 21,652

Inventories 17,264 14,938

Prepaid expenses and other current assets 1,158 1,385

Total current assets 154,644 176,433

Property and equipment, net 49,198 40,108

Long-term deposits and other 69 69

Intangible assets, net 11,259 11,656

Goodwill 7,568 7,482

Total Assets 222,738 235,748

LIABILITIES AND STOCKHOLDERS’ EQUITY

Accounts payable 3,294 8,302

Accrued expenses and other current liabilities 6,638 4,778

Income taxes payable 591 4,198

Total current liabilities 10,523 17,278

Other long-term liabilities 1,173 781

Long-term deferred revenue 56 66

Deferred tax liability 6,570 6,775

Commitments and contingencies (Note 12)

Stockholders’ equity:

Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively

Common stock, $.01 par value; 60,000,000 and 30,000,000 shares authorized, 14,777,663 and 15,036,808 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively 148 150

Additional paid-in-capital 59,506 81,685

Accumulated other comprehensive loss (6,410) (6,649)

Retained earnings 151,172 135,662

Total stockholders’ equity 204,416 210,848

Total Liabilities and Stockholders’ Equity $ 222,738 $ 235,748

X

- Definition
Represents deposits and other assets, noncurrent.
+ References
No definition available.
+ Details

Name: anik_DepositsAndOtherAssetsNoncurrent

Namespace Prefix: anik_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(b)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(1))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_AccruedLiabilitiesAndOtherLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669686-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(c).Q3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q1(c))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q2)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780
+ Details

Name: us-gaap_DeferredRevenueNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31917-109318
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26626-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 18 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands

Jun. 30, 2016

Dec. 31, 2015

Accounts receivable, net of reserves $ 220 $ 167

Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01

Preferred stock, shares authorized (in shares) 1,250,000 1,250,000

Preferred stock, shares issued (in shares) 0 0

Preferred stock, shares outstanding (in shares) 0 0

Common stock, par value (in dollars per share) $ 0.01 $ 0.01

Common stock, shares authorized (in shares) 60,000,000 30,000,000

Common stock, shares issued (in shares) 14,777,663 15,035,808

Common stock, shares outstanding (in shares) 14,777,663 15,035,808

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66008989&loc=d3e5074-111524
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 19 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Product revenue $ 26,575 $ 22,898 $ 48,853 $ 38,413

Licensing, milestone and contract revenue 6 6 11 11

Total revenue 26,581 22,904 48,864 38,424

Operating expenses:

Cost of product revenue 6,065 5,275 11,490 9,588

Research & development 2,792 1,812 4,951 3,910

Selling, general & administrative 4,255 3,388 8,245 6,993

Total operating expenses 13,112 10,475 24,686 20,491

Income from operations 13,469 12,429 24,178 17,933

Interest income, net 49 24 121 48

Income before income taxes 13,518 12,453 24,299 17,981

Provision for income taxes 4,903 4,634 8,789 6,646

Net income $ 8,615 $ 7,819 $ 15,510 $ 11,335

Basic net income per share:

Net income (in dollars per share) $ 0.59 $ 0.52 $ 1.05 $ 0.76

Basic weighted average common shares outstanding (in shares) 14,679 14,961 14,778 14,934

Diluted net income per share:

Net income (in dollars per share) $ 0.57 $ 0.51 $ 1.02 $ 0.74

Diluted weighted average common shares outstanding (in shares) 15,111 15,336 15,210 15,332

Net income $ 8,615 $ 7,819 $ 15,510 $ 11,335

Other comprehensive income (loss):

Unrealized gain (loss) on securities, net of tax (3) (3)

Foreign currency translation adjustment (536) 420 238 (1,828)

Total other comprehensive income (loss) (536) 417 238 (1,831)

Comprehensive income $ 8,079 $ 8,236 $ 15,748 $ 9,504

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total costs related to goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total costs of sales and operating expenses for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of nonoperating interest income (expense).
+ References
No definition available.
+ Details

Name: us-gaap_InterestIncomeExpenseNonoperatingNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569643-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of other comprehensive income (loss) attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569643-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(d))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueServicesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 20 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Cash flows from operating activities:

Net income $ 15,510 $ 11,335

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization 1,901 1,827

Stock-based compensation expense 1,478 1,064

Deferred income taxes (252) (428)

Provision for doubtful accounts 52

Provision for inventory 181 68

Tax benefit from equity awards (419) (934)

Changes in operating assets and liabilities:

Accounts receivable (2,932) (2,389)

Inventories (2,438) 496

Prepaid expenses, other current and long-term assets 186 459

Accounts payable (4,252) 559

Accrued expenses and other current liabilities 446 (264)

Deferred revenue (45) (5)

Income taxes payable (3,169) 3,194

Other long-term liabilities 396 (98)

Net cash provided by operating activities 6,643 14,884

Cash flows from investing activities:

Proceeds from maturity of investments 27,750 10,250

Purchase of investments (22,499) (22,018)

Purchase of property and equipment (9,869) (1,134)

Net cash used in investing activities (4,618) (12,902)

Cash flows from financing activities:

Repurchases of common stock (25,000)

Proceeds from exercise of equity awards 922 969

Tax benefit from equity awards 419 934

Net cash (used in) provided by financing activities (23,659) 1,903

Exchange rate impact on cash 52 (121)

Increase (decrease) in cash and cash equivalents (21,582) 3,764

Cash and cash equivalents at beginning of period 110,707 100,156

Cash and cash equivalents at end of period 89,125 103,920

Non-cash Investing Activities:

Purchases of property and equipment included in accounts payable and accrued expenses $ 2,128 $ 116

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Future cash outflow to pay for purchases of fixed assets that have occurred.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586
+ Details

Name: us-gaap_CapitalExpendituresIncurredButNotYetPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=65896087&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=65896087&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in accrued expenses, and obligations classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in noncurrent operating liabilities classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66092785&loc=d3e4542-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 1C
-URI http://asc.fasb.org/extlink&oid=68049868&loc=SL66093883-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=68049868&loc=SL66093879-108312
+ Details

Name: us-gaap_InventoryWriteDown

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncashInvestingAndFinancingItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.5)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 21 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 1 - Nature of Business
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Nature of Operations [Text Block]

1.

Nature of Business

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions by providing innovative and differentiated therapeutic pain management solutions along the continuum of care, from palliative care to regenerative medicine. The Company has over two decades of expertise developing, manufacturing, and commercializing more than 20 products, in markets across the globe, based on the Company’s proprietary hyaluronic acid technology. The Company’s orthopedic medicine portfolio is comprised of marketed (ORTHOVISC and MONOVISC) and pipeline (CINGAL and HYALOFAST in the United States, among others) products to alleviate pain and restore joint function by replenishing depleted HA and aiding cartilage repair and regeneration.

The Company is subject to risks common to companies in the biotechnology and medical device industries including, but not limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, commercialization of existing and new products, and compliance with U.S. Food and Drug Administration (“FDA”) and foreign regulations and approval requirements, as well as the ability to grow the Company’s business through appropriate commercial strategies.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6003-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 2A
-URI http://asc.fasb.org/extlink&oid=64851502&loc=SL51803626-108592
+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 2 - Basis of Presentation
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Business Description and Basis of Presentation [Text Block]

2.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and related notes have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and in accordance with accounting principles generally accepted in the United States (“US GAAP”). The financial statements include the accounts of Anika Therapeutics, Inc. and its subsidiaries. Inter-company transactions and balances have been eliminated. The year-end consolidated balance sheet is derived from the Company’s audited financial statements, but does not include all disclosures required by US GAAP. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to fairly state the condensed consolidated financial position of the Company as of June 30, 2016, the results of its operations for the three- and six-month periods ended June 30, 2016 and 2015, and cash flows for the six-month periods ended June 30, 2016 and 2015.

The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s annual financial statements filed with its Annual Report on Form 10-K for the year ended December 31, 2015. The results of operations for the three- and six-month periods ended June 30, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016. Certain prior period amounts have been reclassified to conform to the current period presentation. There was no impact on operating income.

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 3 - Recent Accounting Pronouncements
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

3.

Recent Accounting Pronouncements

Recently Issued

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 supersedes the revenue recognition requirements in “Topic 605, Revenue Recognition” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
In July 2015, the FASB issued a deferral of ASU 2014-09 of one year making it effective for annual reporting periods beginning on or after December 15, 2017 while also providing for early adoption not to occur before the original effective date. The Company is assessing the appropriate method for implementing ASU 2014-09, as well as the impact the adoption of ASU 2014-09 will have on its consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU 2016-02 amends existing leasing accounting requirements. The most significant change will result in the recognition of lease assets and lease liabilities by lessees for virtually all leases. The new guidance will also require significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Upon adoption, entities are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. Early adoption is permitted, and a number of optional practical expedients may be elected to simplify the impact of adoption. The Company is evaluating the impact of adopting this guidance.

In March 2016, the FASB issued ASU No. 2016-09, Compensation (Topic 718) Stock Compensation. ASU 2016-09 identifies areas for simplification involving several aspects of accounting for share-based payment transactions, including the income tax consequences, classification of awards as equity or liabilities, an option to recognize gross stock compensation expense with actual forfeitures recognized as they occur, as well as certain classifications on the statement of cash flows. Early adoption is permitted. The Company is assessing ASU 2016-09 and the impact that adopting this new accounting standard will have on its consolidated financial statements and footnote disclosures.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.

Recently Adopted

In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330) Simplifying the Measurement of Inventory. ASU 2015-11 more closely aligns the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The provisions of ASU 2015-11 are effective for annual and interim periods beginning after December 15, 2016. ASU 2015-11 should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The adoption of this amendment did not have a material impact on the Company’s financial position or results of operations.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=66092750

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 4 - Investments
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Cash and Cash Equivalents Disclosure [Text Block]

4.

Investments

All of the Company’s investments are classified as available-for-sale and are carried at fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income, net of related income taxes. The Company held bank certificates of deposit of $22.5 million and $25.8 million at June 30, 2016 and December 31, 2015, respectively. The Company also held corporate debt securities of $2.0 million at December 31, 2015. There were no unrealized gains or losses on the Company’s available-for-sale securities at June 30, 2016 or December 31, 2015.

X

- Definition
The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 6.H.3)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13728-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951
+ Details

Name: us-gaap_CashAndCashEquivalentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 25 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 5 - Fair Value Measurements
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Fair Value Disclosures [Text Block]

5.

Fair Value Measurements

Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability. As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows: (Level 1) observable inputs such as quoted prices in active markets for identical assets or liabilities; (Level 2) significant other observable inputs that are observable either directly or indirectly; and (Level 3) significant unobservable inputs for which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, the Company records its investments at fair value.

The Company’s investments are all classified within Level 2 of the fair value hierarchy. These investments classified within Level 2 of the fair value hierarchy are valued based on matrix pricing compiled by third party pricing vendors, using observable market inputs such as interest rates, yield curves, and credit risk.

The fair value hierarchy of the Company’s cash equivalents and investments at fair value is as follows:

Fair Value Measurements at Reporting

Date Using

Quoted Prices in

Active Markets Significant Other Significant

for Identical Assets Observable Inputs Unobservable Inputs

June 30, 2016 (Level 1) (Level 2) (Level 3)

Cash equivalents:

Money market funds $ 67,001 $ - $ 67,001 $ -

Investments:

Bank certificates of deposit $ 22,500 $ - $ 22,500 $ -

Fair Value Measurements at Reporting

Date Using

Quoted Prices in

Active Markets Significant Other Significant

for Identical Assets Observable Inputs Unobservable Inputs

December 31, 2015 (Level 1) (Level 2) (Level 3)

Cash equivalents:

Money market funds $ 61,385 $ - $ 61,385 $ -

Bank certificates of deposit 250 - 250 -

Total cash equivalents $ 61,635 $ - $ 61,635 $ -

Investments:

Corporate debt securities $ 2,001 $ - $ 2,001 $ -

Bank certificates of deposit 25,750 - 25,750 -

Total investments $ 27,751 $ - $ 27,751 $ -

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 6 - Equity Incentive Plan
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

6.

Equity Incentive Plan

The Company estimates the fair value of stock options and stock appreciation rights (“SARs”) using the Black-Scholes valuation model. Fair value of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) are measured by the grant-date price of the Company’s shares. The fair value of each stock option award during the three- and six-month periods ended June 30, 2016 and 2015, respectively, was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

Six Months Ended June 30,

2016 2015

Risk free interest rate 0.94% - 1.40% 1.15% - 1.46%

Expected volatility 49.47% - 51.61% 53.15% - 54.65%

Expected life (years) 4.5 4.5

Expected dividend yield 0.00% 0.00%

The Company recorded $0.7 million and $0.5 million of share-based compensation expense for the three-month periods ended June 30, 2016 and 2015, respectively, for equity compensation awards. The Company recorded $1.5 million and $1.1 million of share-based compensation expense for the six-month periods ended June 30, 2016 and 2015, respectively, for equity compensation awards. The Company presents the expenses related to stock-based compensation awards in the same expense line items as cash compensation paid to the respective recipients.

During the three-month period ended June 30, 2016, the Company granted under the Equity Incentive Plan (“Plan”) a total of 43,000 stock options. During the six-month period ended June 30, 2016, the Company granted under the Plan a total of 331,705 stock options including 46,300 RSAs and 11,805 RSUs. All of the RSUs were granted to directors of the Company and vest over a one year period. The stock options and RSAs granted to employees generally become exercisable or vest ratably over four years from the date of grant.

A portion of the stock options granted during the six-month period ended June 30, 2016 contained certain performance features, as compared to established targets, in addition to time-based vesting conditions. For performance-based awards with financial achievement targets, the Company recognizes expense using the graded vesting methodology based on the number of shares expected to vest. Compensation cost associated with performance grants is estimated using the Black-Scholes valuation method multiplied by the expected number of shares to be issued, which is adjusted based on the estimated probabilities of achieving the performance goals. Changes to the probability assessment and the estimated shares expected to vest will result in adjustments to the related share-based compensation expense that will be recorded in the period of the change. If the performance targets are not achieved, no compensation cost is recognized and any previously recognized compensation cost is reversed.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 7 - Earnings Per Share ("EPS")
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Earnings Per Share [Text Block]

7.

Earnings Per Share (“EPS”)

Basic EPS is calculated by dividing net income by the weighted average number of shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic earnings per share. Diluted EPS is calculated by dividing net income by the weighted average number of shares outstanding plus the dilutive effect, if any, of outstanding stock options, SARs, RSAs, and RSUs using the treasury stock method.

The following table provides share information used in the calculation of the Company's basic and diluted earnings per share:

Three Months Ended June 30, Six Months Ended June 30,

2016 2015 2016 2015

Shares used in the calculation of basic earnings per share 14,679 14,961 14,778 14,934

Effect of dilutive securities:

Stock options, SARs, and RSAs 432 375 432 398

Diluted shares used in the calculation of earnings per share 15,111 15,336 15,210 15,332

Equity awards of 0.3 million shares were outstanding for the three- and six-month periods ended June 30, 2016 and were not included in the computation of diluted earnings per share because the awards’ impact on earnings per share was anti-dilutive. Equity awards of 0.2 million shares were outstanding for the three- and six-month periods ended June 30, 2015, respectively, and were not included in the computation of diluted earnings per share because the awards’ impact on earnings per share was anti-dilutive.

On February 26, 2016, the Company entered into an accelerated stock repurchase agreement with Morgan Stanley & Co. LLC (“Morgan Stanley”) pursuant to a Fixed Dollar Accelerated Share Repurchase Transaction (“ASR Agreement") to purchase $25.0 million of shares of its common stock. Pursuant to the terms of the ASR Agreement, the Company paid Morgan Stanley $25.0 million in cash and received an initial delivery of 377,155 shares of the Company’s common stock on February 29, 2016 based on a closing market price of $46.40 and the applicable contractual discount. This is approximately 70% of the total number of shares of expected to be repurchased under the ASR Agreement. These shares are held by the Company as authorized but unissued shares pursuant to Massachusetts law. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted net income per share.

As of June 30, 2016, the Company has approximately $7.5 million remaining under the ASR Agreement which was recorded as an equity forward sale contract and was included in additional paid-in capital in stockholders' equity in the condensed consolidated balance sheet as it met the criteria for equity accounting. Pursuant to the terms of the ASR Agreement, the final number of shares and the average purchase price will be determined at the end of the applicable purchase period, which is expected to occur in the third quarter of 2016. Upon settlement of the ASR Agreement, the Company may receive additional shares or be required to either pay additional cash or deliver shares of our common stock (at its option) to Morgan Stanley, based on the forward price. If the ASR Agreement had been settled as of June 30, 2016, based on the volume-weighted average price since the effective date of the ASR Agreement, Morgan Stanley would have been required to deliver approximately 0.2 million additional shares to the Company. However, the Company cannot predict the final number of shares to be received, or delivered, by it under the ASR Agreement, and, as such, these shares are not included in the calculation of diluted weighted-average common shares outstanding during the period because the effect is anti-dilutive.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 8 - Inventories
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Inventory Disclosure [Text Block]

8.

Inventories

Inventories consist of the following:

June 30, December 31,

2016 2015

Raw materials $ 6,812 $ 5,780

Work-in-process 6,140 5,656

Finished goods 4,312 3,502

Total $ 17,264 $ 14,938

Inventories are stated at the lower of cost or market, with cost being determined using the first-in, first-out method. Work-in-process and finished goods inventories include materials, labor, and manufacturing overhead. Inventory costs associated with product candidates that have not yet received regulatory approval are capitalized if the Company believes there is probable future commercial use and future economic benefit.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766
+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 9 - Intangible Assets
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

9.

Intangible Assets

In connection with the 2009 acquisition of Anika Therapeutics S.r.l. (“Anika S.r.l.”), the Company acquired various intangible assets and goodwill. The Company evaluated the various intangible assets and related cash flows from these intangible assets, as well as the useful lives and amortization methods related to these intangible assets. The in-process research and development (“IPR&D”) intangible assets initially have indefinite lives and are reviewed periodically to assess the project status, valuation, and disposition, including write-off(s) for abandoned projects. Until such determination is made, they are not amortized.

Intangible assets as of June 30, 2016 and December 31, 2015 consist of the following:

June 30, 2016 December 31, 2015

Gross Value Accumulated Currency Translation Adjustment Accumulated Amortization Net Book Value Net Book Value Useful Life

Developed technology $ 17,100 $ (3,108 ) $ (6,373 ) $ 7,619 $ 7,959 15

In-process research & development 4,406 (1,286 ) - 3,120 3,099 Indefinite

Distributor relationships 4,700 (415 ) (4,285 ) - - 5

Patents 1,000 (186 ) (357 ) 457 473 16

Elevess trade name 1,000 - (937 ) 63 125 9

Total $ 28,206 $ (4,995 ) $ (11,952 ) $ 11,259 $ 11,656

The aggregate amortization expense related to intangible assets was $0.3 million for the three-month periods ended June 30, 2016 and 2015, respectively. The aggregate amortization expense related to intangible assets was $0.6 million and $0.5 million for the six-month periods ended June 30, 2016 and 2015, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 10 - Goodwill
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Goodwill Disclosure [Text Block]

10.

Goodwill

Through June 30, 2016, there have not been any events or changes in circumstances that indicate that the carrying value of goodwill may not be recoverable. Changes in the carrying value of goodwill were as follows:

Six Months Ended
June 30, Twelve Months
Ended December 31,

2016 2015

Balance, beginning $ 7,482 $ 8,339

Effect of foreign currency adjustments 86 (857 )

Balance, ending $ 7,568 $ 7,482

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 11 - Accrued Expenses
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

11.

Accrued Expenses

Accrued expenses consist of the following:

June 30, December 31,

2016 2015

Compensation and related expenses $ 2,416 $ 3,082

Facility construction costs 1,769 415

Research grants 481 381

Professional fees 889 210

Clinical trial costs 339 252

Other 744 438

Total $ 6,638 $ 4,778

X

- Definition
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 12 - Commitments and Contingencies
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

12.

Commitments and Contingencies

In certain of its contracts, the Company warrants to its customers that the products it manufactures conform to the product specifications as in effect at the time of delivery of the specific product. The Company may also warrant that the products it manufactures do not infringe, violate, or breach any U.S. patent or intellectual property right, trade secret, or other proprietary information of any third party. On occasion, the Company contractually indemnifies its customers against any and all losses arising out of, or in any way connected with, any claim or claims of breach of its warranties or any actual or alleged defect in any product caused by the negligent acts or omissions of the Company. The Company maintains a products liability insurance policy that limits its exposure to these risks. Based on the Company’s historical activity, in combination with its liability insurance coverage, the Company believes the estimated fair value of these indemnification agreements is immaterial. The Company had no accrued warranties at June 30, 2016 or December 31, 2015, respectively, and has no history of claims paid.

The Company is also involved in various legal proceedings arising in the normal course of business. Although the outcomes of these legal proceedings are inherently difficult to predict, the Company does not expect the resolution of these legal proceedings to have a material adverse effect on its financial position, results of operations, or cash flow.

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73718637&loc=d3e25287-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 13 - Leases
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Leases of Lessee Disclosure [Text Block]

13.

Leases

On October 9, 2015, Anika S.r.l. entered into a build-to-suit lease agreement with Consorzio Zona Industriale E Porto Fluviale di Padova (“ZIP”), as landlord, pursuant to which Anika S.r.l. will lease a new European headquarters facility, consisting of approximately 33,000 square feet of general office, research and development, training, and warehousing space located in Padova, Italy. The lease has an initial term of fifteen years, which is expected to commence during the fourth quarter of 2016 once construction of the facility is completed. The lease will automatically renew for up to three additional six-year terms, subject to certain terms and conditions. The Company has the ability to withdraw from this lease subject to certain financial penalties after six years and with no penalties after the ninth year. Beginning on the commencement date, the lease provides for an initial yearly rent of approximately $0.4 million.

Construction of the new facility began in the first quarter of 2016 and is expected to be completed in late 2016. During the period of construction the Company is considered the deemed owner of the facility. Accordingly, the landlord's costs of constructing the facility are required to be capitalized, as a non-cash transaction, offset by a corresponding facility lease obligation in the Company’s consolidated balance sheet. As of June 30, 2016, the Company has recorded a construction-in-process asset of approximately $0.9 million. This includes $0.5 million incurred by ZIP for the construction of the new facility, which was recorded as a facility lease obligation within other long-term liabilities on the balance sheet.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6452660&loc=d3e36991-112694

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 1,3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_LeasesOfLesseeDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 14 - Income Taxes
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Income Tax Disclosure [Text Block]

14.

Income Taxes

Provisions for income taxes were $4.9 million and $8.8 million for the three- and six-month periods ended June 30, 2016, based on effective tax rates of 36.3% and 36.2%, respectively. Provisions for income taxes were $4.6 million and $6.6 million for the three- and six-month periods ended June 30, 2015, based on effective tax rates of 37% for both periods. The increase in income taxes for the three- and six-month period ended June 30, 2016 resulted from higher net income as compared to the same periods in the prior year. The net decrease in the effective tax rate
for the three- and six-month period ended June 30, 2016, as compared to the same period in 2015,
was primarily due to an increase in the expected tax credit for research and development expenditures.

The Company files income tax returns in the United States on a federal basis, in certain U.S. states, and in Italy. The associated tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. The Company’s filings from 2012 through the present tax year remain subject to examination by the IRS and other taxing authorities for U.S. federal and state tax purposes. The Company currently has a tax audit in progress in the United States and does not anticipate that the audit will have a material impact on its financial statements. The Company’s filings from 2010 through the present tax year remain subject to examination by the appropriate governmental authorities in Italy.

In connection with the preparation of the financial statements, the Company performed an analysis to ascertain if it was more likely than not that it would be able to utilize, in future periods, the net deferred tax assets associated with its net operating loss carryforward. The Company concluded that the positive evidence outweighs the negative evidence and, thus, those deferred tax assets are realizable on a “more likely than not” basis. As such, the Company did not record a valuation allowance at June 30, 2016 or December 31, 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 15 - Segment and Geographic Information
6 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

15.

Segment and Geographic Information

The Company has one reportable operating segment, for the purposes of assessing performance and deciding how to allocate resources.

Product revenue by product group is as follows:

Three Months Ended June 30, Six Months Ended June 30,

2016 2015 2016 2015

Orthobiologics $ 23,304 $ 19,283 $ 42,891 $ 31,255

Surgical 1,433 1,647 2,751 3,037

Dermal 582 303 963 719

Other 1,256 1,665 2,248 3,402

Product Revenue $ 26,575 $ 22,898 $ 48,853 $ 38,413

Total revenue by geographic location and as a percentage of overall total revenue for the three-month periods ended June 30, 2016 and 2015 are as follows:

Three Months Ended June 30,

2016 2015

Total Percentage of Total Percentage of

Revenue Revenue Revenue Revenue

Geographic Location:

United States $ 21,895 82 % $ 19,218 84 %

Europe 2,977 11 % 2,331 10 %

Other 1,709 7 % 1,355 6 %

Total Revenue $ 26,581 100 % $ 22,904 100 %

Six Months Ended June 30,

2016 2015

Total Percentage of Total Percentage of

Revenue Revenue Revenue Revenue

Geographic Location:

United States $ 39,906 82 % $ 31,809 83 %

Europe 5,542 11 % 4,317 11 %

Other 3,416 7 % 2,298 6 %

Total $ 48,864 100 % $ 38,424 100 %

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 5 - Fair Value Measurements (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Fair Value, Assets Measured on Recurring Basis [Table Text Block]

Fair Value Measurements at Reporting

Date Using

Quoted Prices in

Active Markets Significant Other Significant

for Identical Assets Observable Inputs Unobservable Inputs

June 30, 2016 (Level 1) (Level 2) (Level 3)

Cash equivalents:

Money market funds $ 67,001 $ - $ 67,001 $ -

Investments:

Bank certificates of deposit $ 22,500 $ - $ 22,500 $ -

Fair Value Measurements at Reporting

Date Using

Quoted Prices in

Active Markets Significant Other Significant

for Identical Assets Observable Inputs Unobservable Inputs

December 31, 2015 (Level 1) (Level 2) (Level 3)

Cash equivalents:

Money market funds $ 61,385 $ - $ 61,385 $ -

Bank certificates of deposit 250 - 250 -

Total cash equivalents $ 61,635 $ - $ 61,635 $ -

Investments:

Corporate debt securities $ 2,001 $ - $ 2,001 $ -

Bank certificates of deposit 25,750 - 25,750 -

Total investments $ 27,751 $ - $ 27,751 $ -

X

- Definition
Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19190-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 6 - Equity Incentive Plan (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Six Months Ended June 30,

2016 2015

Risk free interest rate 0.94% - 1.40% 1.15% - 1.46%

Expected volatility 49.47% - 51.61% 53.15% - 54.65%

Expected life (years) 4.5 4.5

Expected dividend yield 0.00% 0.00%

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 7 - Earnings Per Share ("EPS") (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Three Months Ended June 30, Six Months Ended June 30,

2016 2015 2016 2015

Shares used in the calculation of basic earnings per share 14,679 14,961 14,778 14,934

Effect of dilutive securities:

Stock options, SARs, and RSAs 432 375 432 398

Diluted shares used in the calculation of earnings per share 15,111 15,336 15,210 15,332

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 39 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 8 - Inventories (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Inventory, Current [Table Text Block]

June 30, December 31,

2016 2015

Raw materials $ 6,812 $ 5,780

Work-in-process 6,140 5,656

Finished goods 4,312 3,502

Total $ 17,264 $ 14,938

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 9 - Intangible Assets (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Finite-Lived and Indefinite-Lived Intangible Assets by Major Class [Table Text Block]

June 30, 2016 December 31, 2015

Gross Value Accumulated Currency Translation Adjustment Accumulated Amortization Net Book Value Net Book Value Useful Life

Developed technology $ 17,100 $ (3,108 ) $ (6,373 ) $ 7,619 $ 7,959 15

In-process research & development 4,406 (1,286 ) - 3,120 3,099 Indefinite

Distributor relationships 4,700 (415 ) (4,285 ) - - 5

Patents 1,000 (186 ) (357 ) 457 473 16

Elevess trade name 1,000 - (937 ) 63 125 9

Total $ 28,206 $ (4,995 ) $ (11,952 ) $ 11,259 $ 11,656

X

- Definition
Tabular disclosure of finite-lived and indefinite-lived intangible assets by major class.
+ References
No definition available.
+ Details

Name: anik_ScheduleOfFinitelivedAndIndefinitelivedIntangibleAssetsByMajorClassTableTextBlock

Namespace Prefix: anik_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 10 - Goodwill (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Goodwill [Table Text Block]

Six Months Ended
June 30, Twelve Months
Ended December 31,

2016 2015

Balance, beginning $ 7,482 $ 8,339

Effect of foreign currency adjustments 86 (857 )

Balance, ending $ 7,568 $ 7,482

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 42 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 11 - Accrued Expenses (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

June 30, December 31,

2016 2015

Compensation and related expenses $ 2,416 $ 3,082

Facility construction costs 1,769 415

Research grants 481 381

Professional fees 889 210

Clinical trial costs 339 252

Other 744 438

Total $ 6,638 $ 4,778

X

- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 15 - Segment and Geographic Information (Tables)
6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Three Months Ended June 30, Six Months Ended June 30,

2016 2015 2016 2015

Orthobiologics $ 23,304 $ 19,283 $ 42,891 $ 31,255

Surgical 1,433 1,647 2,751 3,037

Dermal 582 303 963 719

Other 1,256 1,665 2,248 3,402

Product Revenue $ 26,575 $ 22,898 $ 48,853 $ 38,413

Schedule of Revenue and Operating Income by Geographical Areas [Table Text Block]

Three Months Ended June 30,

2016 2015

Total Percentage of Total Percentage of

Revenue Revenue Revenue Revenue

Geographic Location:

United States $ 21,895 82 % $ 19,218 84 %

Europe 2,977 11 % 2,331 10 %

Other 1,709 7 % 1,355 6 %

Total Revenue $ 26,581 100 % $ 22,904 100 %

Six Months Ended June 30,

2016 2015

Total Percentage of Total Percentage of

Revenue Revenue Revenue Revenue

Geographic Location:

United States $ 39,906 82 % $ 31,809 83 %

Europe 5,542 11 % 4,317 11 %

Other 3,416 7 % 2,298 6 %

Total $ 48,864 100 % $ 38,424 100 %

X

- Definition
Represents schedule of revenue and operating income, by geographical areas.
+ References
No definition available.
+ Details

Name: anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock

Namespace Prefix: anik_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599
+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 1 - Nature of Business (Details Textual)

Jun. 30, 2016

Number of Products Developed, Manufactured, and Commercialized 20

X

- Definition
Represents the number of products the Company has developed, manufactured, and commercialized throughout the course of its existence.
+ References
No definition available.
+ Details

Name: anik_NumberOfProductsDevelopedManufacturedAndCommercialized

Namespace Prefix: anik_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

XML 45 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 4 - Investments (Details Textual) - USD ($)

Jun. 30, 2016

Dec. 31, 2015

Certificates of Deposit [Member]

Available-for-sale Securities $ 22,500,000 $ 25,800,000

Corporate Debt Securities [Member]

Available-for-sale Securities 2,000,000

Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax $ 0 $ 0

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65884222&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before tax of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.
+ References
No definition available.
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 46 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 5 - Fair Value of Financial Instruments (Details) - USD ($)
$ in Thousands

Jun. 30, 2016

Dec. 31, 2015

Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]

Cash equivalents $ 67,001 $ 61,385

Money Market Funds [Member]

Cash equivalents 67,001 61,385

Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]

Cash equivalents 250

Investments 22,500 25,750

Certificates of Deposit [Member]

Cash equivalents 250

Investments 22,500 25,750

Corporate Debt Securities [Member]

Investments 2,001

Fair Value, Inputs, Level 2 [Member]

Cash equivalents 61,635

Cash equivalents 61,635

Investments $ 22,500 $ 27,751

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016
+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26626-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 6 - Equity Incentive Plan (Details Textual) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Restricted Stock and Restricted Stock Units [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 0.7 $ 0.5 $ 1.5 $ 1.1

Restricted Stock [Member] | Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 46,300

Employee Stock Option [Member] | Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 43,000 331,705

Restricted Stock Units (RSUs) [Member] | Plan [Member] | Board of Directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 11,805

Restricted Stock Units (RSUs) [Member] | Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 1 year

X

- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=anik_RestrictedStockAndRestrictedStockUnitsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=anik_PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=anik_BoardOfDirectorsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 6 - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards (Details)
6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Minimum [Member]

Risk free interest rate 0.94% 1.15%

Expected volatility 49.47% 53.15%

Maximum [Member]

Risk free interest rate 1.40% 1.46%

Expected volatility 51.61% 54.65%

Expected life (years) 4 years 182 days 4 years 182 days

Expected dividend yield 0.00% 0.00%

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 49 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 7 - Earnings Per Share ("EPS") (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2016

Feb. 29, 2016

Feb. 26, 2016

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Accelerated Stock Repurchase [Member] | Morgan Stanley & Co., LLC [Member] | Common Stock [Member]

Stock Repurchase Program, Authorized Amount $ 25,000

Accelerated Share Repurchases, Initial Price Paid Per Share $ 46.40

Stock Repurchase Program, Percentage Repurchased 70.00%

Accelerated Stock Repurchase [Member] | Morgan Stanley & Co., LLC [Member] | Additional Paid-in Capital [Member]

Stock Repurchase Program, Remaining Authorized Repurchase Amount $ 7,500 $ 7,500 $ 7,500

Accelerated Stock Repurchase [Member] | Morgan Stanley & Co., LLC [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 200,000

Payments for Repurchase of Common Stock $ 25,000

Stock Repurchased and Retired During Period, Shares 377,155

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 300,000 200,000 300,000 200,000

Payments for Repurchase of Common Stock $ 25,000

X

- Definition
The percentage of shares repurchased under the stock repurchase program.
+ References
No definition available.
+ Details

Name: anik_StockRepurchaseProgramPercentageRepurchased

Namespace Prefix: anik_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 25
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653
+ Details

Name: us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stock repurchase plan authorized.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramAuthorizedAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount remaining of a stock repurchase plan authorized.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares that have been repurchased and retired during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockRepurchasedAndRetiredDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ShareRepurchaseProgramAxis=anik_AcceleratedStockRepurchaseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CounterpartyNameAxis=anik_MorganStanleyCoLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 50 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 7 - Basic and Diluted Earnings Per Share (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Shares used in the calculation of basic earnings per share (in shares) 14,679 14,961 14,778 14,934

Effect of dilutive securities:

Stock options, SARs, and RSAs (in shares) 432 375 432 398

Diluted shares used in the calculation of earnings per share (in shares) 15,111 15,336 15,210 15,332

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 51 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 8 - Inventories (Details) - USD ($)
$ in Thousands

Jun. 30, 2016

Dec. 31, 2015

Raw materials $ 6,812 $ 5,780

Work-in-process 6,140 5,656

Finished goods 4,312 3,502

Total $ 17,264 $ 14,938

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729
+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729
+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729
+ Details

Name: us-gaap_InventoryWorkInProcessNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 52 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 9 - Intangible Assets (Details Textual) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Amortization of Intangible Assets $ 0.3 $ 0.3 $ 0.6 $ 0.5

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 53 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 9 - Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Jun. 30, 2016

Developed Technology Rights [Member]

Gross Value $ 17,100

Accumulated Currency Translation Adjustment (3,108)

Accumulated Amortization (6,373)

Net Book Value $ (7,959) 7,619

Net Book Value $ 7,959 (7,619)

Useful Life 15 years

In Process Research and Development [Member]

Gross Value 4,406

Accumulated Currency Translation Adjustment (1,286)

Net Book Value $ (3,099) 3,120

Net Book Value $ 3,099 (3,120)

Distribution Rights [Member]

Gross Value 4,700

Accumulated Currency Translation Adjustment (415)

Accumulated Amortization (4,285)

Useful Life 5 years

Patents [Member]

Gross Value 1,000

Accumulated Currency Translation Adjustment (186)

Accumulated Amortization (357)

Net Book Value $ (473) 457

Net Book Value $ 473 (457)

Useful Life 16 years

Elevess Trade Name [Member]

Gross Value 1,000

Accumulated Amortization (937)

Net Book Value $ (125) 63

Net Book Value $ 125 (63)

Useful Life 9 years

Gross Value 28,206

Accumulated Currency Translation Adjustment (4,995)

Accumulated Amortization (11,952)

Net Book Value $ 11,656 11,259

Net Book Value $ (11,656) $ (11,259)

X

- Definition
Represents the amount of the accumulated currency translation adjustment.
+ References
No definition available.
+ Details

Name: anik_AccumulatedCurrencyTranslationAdjustment

Namespace Prefix: anik_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated amortization of intangible assets, excluding goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_IntangibleAssetsGrossExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=anik_ElevessTradeNameMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 10 - Changes in the Carrying Value of Goodwill (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended

Jun. 30, 2016

Dec. 31, 2015

Balance $ 7,482 $ 8,339

Effect of foreign currency adjustments 86 (857)

Balance $ 7,568 $ 7,482

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillForeignCurrencyTranslationGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 55 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 11 - Accrued Expenses (Details) - USD ($)
$ in Thousands

Jun. 30, 2016

Dec. 31, 2015

Compensation and related expenses $ 2,416 $ 3,082

Facility construction costs 1,769 415

Research grants 481 381

Professional fees 889 210

Clinical trial costs 339 252

Other 744 438

Total $ 6,638 $ 4,778

X

- Definition
Represents accrued clinical trial costs current.
+ References
No definition available.
+ Details

Name: anik_AccruedClinicalTrialCostsCurrent

Namespace Prefix: anik_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Represents accrued research grants current.
+ References
No definition available.
+ Details

Name: anik_AccruedResearchGrantsCurrent

Namespace Prefix: anik_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ConstructionPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 56 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 12 - Commitments and Contingencies (Details Textual) - USD ($)

Jun. 30, 2016

Dec. 31, 2015

Standard and Extended Product Warranty Accrual $ 0 $ 0

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (c)(5)
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ProductWarrantyAccrual

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 57 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 13 - Leases (Details Textual) - European Headquarters Facility [Member]
$ in Millions
6 Months Ended

Oct. 09, 2015

ft²

Mar. 31, 2016

USD ($)

Jun. 30, 2016

USD ($)

Area of Real Estate Property | ft² 33,000

Lessee Leasing Arrangements, Term of Contract 15 years

Lessee Leasing Arrangements, Number of Renewal Terms 3

Lessee Leasing Arrangements, Renewal Term 6 years

Lessee Leasing Arrangements Ability to Withdraw With Penalty 6 years

Lessee Leasing Arrangements Ability to Withdrawn Without Penalty 9 years

Lessee Leasing Arrangements Initial Yearly Rent $ 0.4

Construction in Progress, Gross $ 0.9

Build-to-suit Lease Agreement, Offsetting Facility Lease Obligation $ 0.5

X

- Definition
Represents the amount of the offsetting facility lease obligation under a build-to-suit lease agreement.
+ References
No definition available.
+ Details

Name: anik_BuildToSuitLeaseAgreementOffsettingFacilityLeaseObligation

Namespace Prefix: anik_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Term of the lessee's leasing arrangement ability to withdraw with penalties, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: anik_LesseeLeasingArrangementsAbilityToWithdrawWithPenalty

Namespace Prefix: anik_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of the lessee's leasing arrangement ability to withdraw without penalties, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: anik_LesseeLeasingArrangementsAbilityToWithdrawnWithoutPenalty

Namespace Prefix: anik_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of the lessee's leasing arrangement initial yearly rent.
+ References
No definition available.
+ Details

Name: anik_LesseeLeasingArrangementsInitialYearlyRent

Namespace Prefix: anik_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Represents the number of renewal terms of a leasing arrangement.
+ References
No definition available.
+ Details

Name: anik_LesseeLeasingArrangementsNumberOfRenewalTerms

Namespace Prefix: anik_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Term of the lessee's leasing arrangement renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: anik_LesseeLeasingArrangementsRenewalTerm

Namespace Prefix: anik_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: anik_LesseeLeasingArrangementsTermOfContract

Namespace Prefix: anik_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Area of a real estate property.
+ References
No definition available.
+ Details

Name: us-gaap_AreaOfRealEstateProperty

Namespace Prefix: us-gaap_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_ConstructionInProgressGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=anik_EuropeanHeadquartersFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 14 - Income Taxes (Details Textual) - USD ($)
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Dec. 31, 2015

Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member] | Earliest Tax Year [Member]

Open Tax Year 2012

Foreign Tax Authority [Member] | Ministry of Economic Affairs and Finance, Italy [Member] | Earliest Tax Year [Member]

Open Tax Year 2010

Income Tax Expense (Benefit) $ 4,903,000 $ 4,634,000 $ 8,789,000 $ 6,646,000

Effective Income Tax Rate Reconciliation, Percent 36.30% 37.00% 36.20% 37.00%

Deferred Tax Assets, Valuation Allowance $ 0 $ 0 $ 0

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Tax year that remains open to examination under enacted tax laws, in CCYY format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32718-109319
+ Details

Name: us-gaap_OpenTaxYear

Namespace Prefix: us-gaap_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 15 - Segment and Geographic Information (Details Textual)
6 Months Ended

Jun. 30, 2016

Number of Reportable Segments 1

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

XML 60 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 15 - Product Revenue by Product Group (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

Orthobiologics [Member]

Product revenue $ 23,304 $ 19,283 $ 42,891 $ 31,255

Surgical [Member]

Product revenue 1,433 1,647 2,751 3,037

Dermal [Member]

Product revenue 582 303 963 719

Other [Member]

Product revenue 1,256 1,665 2,248 3,402

Product revenue $ 26,575 $ 22,898 $ 48,853 $ 38,413

X

- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ProductOrServiceAxis=anik_OrthobiologicsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ProductOrServiceAxis=anik_SurgicalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ProductOrServiceAxis=anik_DermalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ProductOrServiceAxis=anik_OtherMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2

Note 15 - Product Revenue by Geographic Location (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2016

Jun. 30, 2015

Jun. 30, 2016

Jun. 30, 2015

UNITED STATES

Total Revenue $ 21,895 $ 19,218 $ 39,906 $ 31,809

Percentage of Revenue 82.00% 84.00% 82.00% 83.00%

Europe [Member]

Total Revenue $ 2,977 $ 2,331 $ 5,542 $ 4,317

Percentage of Revenue 11.00% 10.00% 11.00% 11.00%

Other Location [Member]

Total Revenue $ 1,709 $ 1,355 $ 3,416 $ 2,298

Percentage of Revenue 7.00% 6.00% 7.00% 6.00%

Total Revenue $ 26,581 $ 22,904 $ 48,864 $ 38,424

Percentage of Revenue 100.00% 100.00% 100.00% 100.00%

X

- Definition
Represents the percentage of net revenue.
+ References
No definition available.
+ Details

Name: anik_PercentageOfNetRevenue

Namespace Prefix: anik_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=anik_OtherLocationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 62 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 63 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 90 169 1 false 36 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.anikatherapeutics.com/20160630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.anikatherapeutics.com/20160630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.anikatherapeutics.com/20160630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Sheet http://www.anikatherapeutics.com/20160630/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-income-unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.anikatherapeutics.com/20160630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Nature of Business Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-1-nature-of-business Note 1 - Nature of Business Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Basis of Presentation Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-2-basis-of-presentation- Note 2 - Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Recent Accounting Pronouncements Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-3-recent-accounting-pronouncements- Note 3 - Recent Accounting Pronouncements Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Investments Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-4-investments Note 4 - Investments Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Fair Value Measurements Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-5-fair-value-measurements Note 5 - Fair Value Measurements Notes 10 false false R11.htm 010 - Disclosure - Note 6 - Equity Incentive Plan Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-6-equity-incentive-plan Note 6 - Equity Incentive Plan Notes 11 false false R12.htm 011 - Disclosure - Note 7 - Earnings Per Share ("EPS") Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-7-earnings-per-share-eps Note 7 - Earnings Per Share ("EPS") Notes 12 false false R13.htm 012 - Disclosure - Note 8 - Inventories Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-8-inventories Note 8 - Inventories Notes 13 false false R14.htm 013 - Disclosure - Note 9 - Intangible Assets Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-9-intangible-assets Note 9 - Intangible Assets Notes 14 false false R15.htm 014 - Disclosure - Note 10 - Goodwill Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-10-goodwill Note 10 - Goodwill Notes 15 false false R16.htm 015 - Document - Note 11 - Accrued Expenses Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-11-accrued-expenses Note 11 - Accrued Expenses Uncategorized 16 false false R17.htm 016 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-12-commitments-and-contingencies Note 12 - Commitments and Contingencies Uncategorized 17 false false R18.htm 017 - Disclosure - Note 13 - Leases Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-13-leases Note 13 - Leases Uncategorized 18 false false R19.htm 018 - Disclosure - Note 14 - Income Taxes Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-14-income-taxes Note 14 - Income Taxes Uncategorized 19 false false R20.htm 019 - Disclosure - Note 15 - Segment and Geographic Information Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-15-segment-and-geographic-information Note 15 - Segment and Geographic Information Uncategorized 20 false false R21.htm 020 - Disclosure - Note 5 - Fair Value Measurements (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-5-fair-value-measurements-tables Note 5 - Fair Value Measurements (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 6 - Equity Incentive Plan (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-6-equity-incentive-plan-tables Note 6 - Equity Incentive Plan (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 7 - Earnings Per Share ("EPS") (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-7-earnings-per-share-eps-tables Note 7 - Earnings Per Share ("EPS") (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 8 - Inventories (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-8-inventories-tables Note 8 - Inventories (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 9 - Intangible Assets (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-9-intangible-assets-tables Note 9 - Intangible Assets (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 10 - Goodwill (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-10-goodwill-tables Note 10 - Goodwill (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 11 - Accrued Expenses (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-11-accrued-expenses-tables Note 11 - Accrued Expenses (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 15 - Segment and Geographic Information (Tables) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-15-segment-and-geographic-information-tables Note 15 - Segment and Geographic Information (Tables) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 1 - Nature of Business (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-1-nature-of-business-details-textual Note 1 - Nature of Business (Details Textual) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 4 - Investments (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-4-investments-details-textual Note 4 - Investments (Details Textual) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 5 - Fair Value of Financial Instruments (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-5-fair-value-of-financial-instruments-details Note 5 - Fair Value of Financial Instruments (Details) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 6 - Equity Incentive Plan (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-6-equity-incentive-plan-details-textual Note 6 - Equity Incentive Plan (Details Textual) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 6 - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-6-assumptions-used-to-estimate-fair-value-of-stock-options-and-stock-appreciation-rights-awards-details Note 6 - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards (Details) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 7 - Earnings Per Share ("EPS") (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-7-earnings-per-share-eps-details-textual Note 7 - Earnings Per Share ("EPS") (Details Textual) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 7 - Basic and Diluted Earnings Per Share (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-7-basic-and-diluted-earnings-per-share-details Note 7 - Basic and Diluted Earnings Per Share (Details) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 8 - Inventories (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-8-inventories-details Note 8 - Inventories (Details) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 9 - Intangible Assets (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-9-intangible-assets-details-textual Note 9 - Intangible Assets (Details Textual) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 9 - Intangible Assets (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-9-intangible-assets-details Note 9 - Intangible Assets (Details) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 10 - Changes in the Carrying Value of Goodwill (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-10-changes-in-the-carrying-value-of-goodwill-details Note 10 - Changes in the Carrying Value of Goodwill (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 11 - Accrued Expenses (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-11-accrued-expenses-details Note 11 - Accrued Expenses (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 13 - Leases (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-13-leases-details-textual Note 13 - Leases (Details Textual) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 14 - Income Taxes (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-14-income-taxes-details-textual Note 14 - Income Taxes (Details Textual) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 15 - Segment and Geographic Information (Details Textual) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-15-segment-and-geographic-information-details-textual Note 15 - Segment and Geographic Information (Details Textual) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 15 - Product Revenue by Product Group (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-15-product-revenue-by-product-group-details Note 15 - Product Revenue by Product Group (Details) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 15 - Product Revenue by Geographic Location (Details) Sheet http://www.anikatherapeutics.com/20160630/role/statement-note-15-product-revenue-by-geographic-location-details Note 15 - Product Revenue by Geographic Location (Details) Uncategorized 46 false false All Reports Book All Reports anik-20160630.xml anik-20160630.xsd anik-20160630_cal.xml anik-20160630_def.xml anik-20160630_lab.xml anik-20160630_pre.xml true true ZIP 68 0001171843-16-011397-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-16-011397-xbrl.zip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end

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2016	Jul. 28, 2016
Document Information [Line Items]
Entity Registrant Name	Anika Therapeutics, Inc.
Entity Central Index Key	0000898437
Trading Symbol	anik
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		14,777,663
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 89,125	$ 110,707
Investments	22,500	27,751
Accounts receivable, net of reserves of $220 and $167 at June 30, 2016 and December 31, 2015, respectively	24,597	21,652
Inventories	17,264	14,938
Prepaid expenses and other current assets	1,158	1,385
Total current assets	154,644	176,433
Property and equipment, net	49,198	40,108
Long-term deposits and other	69	69
Intangible assets, net	11,259	11,656
Goodwill	7,568	7,482
Total Assets	222,738	235,748
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	3,294	8,302
Accrued expenses and other current liabilities	6,638	4,778
Income taxes payable	591	4,198
Total current liabilities	10,523	17,278
Other long-term liabilities	1,173	781
Long-term deferred revenue	56	66
Deferred tax liability	6,570	6,775
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively
Common stock, $.01 par value; 60,000,000 and 30,000,000 shares authorized, 14,777,663 and 15,036,808 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively	148	150
Additional paid-in-capital	59,506	81,685
Accumulated other comprehensive loss	(6,410)	(6,649)
Retained earnings	151,172	135,662
Total stockholders’ equity	204,416	210,848
Total Liabilities and Stockholders’ Equity	$ 222,738	$ 235,748

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Accounts receivable, net of reserves	$ 220	$ 167
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,250,000	1,250,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	60,000,000	30,000,000
Common stock, shares issued (in shares)	14,777,663	15,035,808
Common stock, shares outstanding (in shares)	14,777,663	15,035,808

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Product revenue	$ 26,575	$ 22,898	$ 48,853	$ 38,413
Licensing, milestone and contract revenue	6	6	11	11
Total revenue	26,581	22,904	48,864	38,424
Operating expenses:
Cost of product revenue	6,065	5,275	11,490	9,588
Research & development	2,792	1,812	4,951	3,910
Selling, general & administrative	4,255	3,388	8,245	6,993
Total operating expenses	13,112	10,475	24,686	20,491
Income from operations	13,469	12,429	24,178	17,933
Interest income, net	49	24	121	48
Income before income taxes	13,518	12,453	24,299	17,981
Provision for income taxes	4,903	4,634	8,789	6,646
Net income	$ 8,615	$ 7,819	$ 15,510	$ 11,335
Basic net income per share:
Net income (in dollars per share)	$ 0.59	$ 0.52	$ 1.05	$ 0.76
Basic weighted average common shares outstanding (in shares)	14,679	14,961	14,778	14,934
Diluted net income per share:
Net income (in dollars per share)	$ 0.57	$ 0.51	$ 1.02	$ 0.74
Diluted weighted average common shares outstanding (in shares)	15,111	15,336	15,210	15,332
Net income	$ 8,615	$ 7,819	$ 15,510	$ 11,335
Other comprehensive income (loss):
Unrealized gain (loss) on securities, net of tax		(3)		(3)
Foreign currency translation adjustment	(536)	420	238	(1,828)
Total other comprehensive income (loss)	(536)	417	238	(1,831)
Comprehensive income	$ 8,079	$ 8,236	$ 15,748	$ 9,504

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income	$ 15,510	$ 11,335
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,901	1,827
Stock-based compensation expense	1,478	1,064
Deferred income taxes	(252)	(428)
Provision for doubtful accounts	52
Provision for inventory	181	68
Tax benefit from equity awards	(419)	(934)
Changes in operating assets and liabilities:
Accounts receivable	(2,932)	(2,389)
Inventories	(2,438)	496
Prepaid expenses, other current and long-term assets	186	459
Accounts payable	(4,252)	559
Accrued expenses and other current liabilities	446	(264)
Deferred revenue	(45)	(5)
Income taxes payable	(3,169)	3,194
Other long-term liabilities	396	(98)
Net cash provided by operating activities	6,643	14,884
Cash flows from investing activities:
Proceeds from maturity of investments	27,750	10,250
Purchase of investments	(22,499)	(22,018)
Purchase of property and equipment	(9,869)	(1,134)
Net cash used in investing activities	(4,618)	(12,902)
Cash flows from financing activities:
Repurchases of common stock	(25,000)
Proceeds from exercise of equity awards	922	969
Tax benefit from equity awards	419	934
Net cash (used in) provided by financing activities	(23,659)	1,903
Exchange rate impact on cash	52	(121)
Increase (decrease) in cash and cash equivalents	(21,582)	3,764
Cash and cash equivalents at beginning of period	110,707	100,156
Cash and cash equivalents at end of period	89,125	103,920
Non-cash Investing Activities:
Purchases of property and equipment included in accounts payable and accrued expenses	$ 2,128	$ 116

Note 4 - Investments (Details Textual) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Certificates of Deposit [Member]
Available-for-sale Securities	$ 22,500,000	$ 25,800,000
Corporate Debt Securities [Member]
Available-for-sale Securities		2,000,000
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax	$ 0	$ 0

Note 5 - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Money Market Funds [Member] \| Fair Value, Inputs, Level 2 [Member]
Cash equivalents	$ 67,001	$ 61,385
Money Market Funds [Member]
Cash equivalents	67,001	61,385
Certificates of Deposit [Member] \| Fair Value, Inputs, Level 2 [Member]
Cash equivalents		250
Investments	22,500	25,750
Certificates of Deposit [Member]
Cash equivalents		250
Investments	22,500	25,750
Corporate Debt Securities [Member]
Investments		2,001
Fair Value, Inputs, Level 2 [Member]
Cash equivalents		61,635
Cash equivalents		61,635
Investments	$ 22,500	$ 27,751

Note 6 - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards (Details)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Minimum [Member]
Risk free interest rate	0.94%	1.15%
Expected volatility	49.47%	53.15%
Maximum [Member]
Risk free interest rate	1.40%	1.46%
Expected volatility	51.61%	54.65%
Expected life (years)	4 years 182 days	4 years 182 days
Expected dividend yield	0.00%	0.00%

Note 7 - Earnings Per Share ("EPS") (Details Textual) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended		6 Months Ended
	Jun. 30, 2016	Feb. 29, 2016	Feb. 26, 2016	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Accelerated Stock Repurchase [Member] \| Morgan Stanley & Co., LLC [Member] \| Common Stock [Member]
Stock Repurchase Program, Authorized Amount			$ 25,000
Accelerated Share Repurchases, Initial Price Paid Per Share		$ 46.40
Stock Repurchase Program, Percentage Repurchased		70.00%
Accelerated Stock Repurchase [Member] \| Morgan Stanley & Co., LLC [Member] \| Additional Paid-in Capital [Member]
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 7,500			$ 7,500		$ 7,500
Accelerated Stock Repurchase [Member] \| Morgan Stanley & Co., LLC [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	200,000
Payments for Repurchase of Common Stock			$ 25,000
Stock Repurchased and Retired During Period, Shares		377,155
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				300,000	200,000	300,000	200,000
Payments for Repurchase of Common Stock						$ 25,000

Note 8 - Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Raw materials	$ 6,812	$ 5,780
Work-in-process	6,140	5,656
Finished goods	4,312	3,502
Total	$ 17,264	$ 14,938

Note 9 - Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016
Developed Technology Rights [Member]
Gross Value		$ 17,100
Accumulated Currency Translation Adjustment		(3,108)
Accumulated Amortization		(6,373)
Net Book Value	$ (7,959)	7,619
Net Book Value	$ 7,959	(7,619)
Useful Life	15 years
In Process Research and Development [Member]
Gross Value		4,406
Accumulated Currency Translation Adjustment		(1,286)
Net Book Value	$ (3,099)	3,120
Net Book Value	$ 3,099	(3,120)
Distribution Rights [Member]
Gross Value		4,700
Accumulated Currency Translation Adjustment		(415)
Accumulated Amortization		(4,285)
Useful Life	5 years
Patents [Member]
Gross Value		1,000
Accumulated Currency Translation Adjustment		(186)
Accumulated Amortization		(357)
Net Book Value	$ (473)	457
Net Book Value	$ 473	(457)
Useful Life	16 years
Elevess Trade Name [Member]
Gross Value		1,000
Accumulated Amortization		(937)
Net Book Value	$ (125)	63
Net Book Value	$ 125	(63)
Useful Life	9 years
Gross Value		28,206
Accumulated Currency Translation Adjustment		(4,995)
Accumulated Amortization		(11,952)
Net Book Value	$ 11,656	11,259
Net Book Value	$ (11,656)	$ (11,259)

Note 10 - Changes in the Carrying Value of Goodwill (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Balance	$ 7,482	$ 8,339
Effect of foreign currency adjustments	86	(857)
Balance	$ 7,568	$ 7,482

Note 11 - Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Compensation and related expenses	$ 2,416	$ 3,082
Facility construction costs	1,769	415
Research grants	481	381
Professional fees	889	210
Clinical trial costs	339	252
Other	744	438
Total	$ 6,638	$ 4,778

Note 13 - Leases (Details Textual) - European Headquarters Facility [Member] $ in Millions		6 Months Ended
	Oct. 09, 2015 ft²	Mar. 31, 2016 USD ($)	Jun. 30, 2016 USD ($)
Area of Real Estate Property \| ft²	33,000
Lessee Leasing Arrangements, Term of Contract	15 years
Lessee Leasing Arrangements, Number of Renewal Terms	3
Lessee Leasing Arrangements, Renewal Term	6 years
Lessee Leasing Arrangements Ability to Withdraw With Penalty	6 years
Lessee Leasing Arrangements Ability to Withdrawn Without Penalty	9 years
Lessee Leasing Arrangements Initial Yearly Rent		$ 0.4
Construction in Progress, Gross			$ 0.9
Build-to-suit Lease Agreement, Offsetting Facility Lease Obligation			$ 0.5

Note 14 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
Note 14 - Income Taxes (Details Textual) - USD ($)	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Domestic Tax Authority [Member] \| Internal Revenue Service (IRS) [Member] \| Earliest Tax Year [Member]
Open Tax Year			2012
Foreign Tax Authority [Member] \| Ministry of Economic Affairs and Finance, Italy [Member] \| Earliest Tax Year [Member]
Open Tax Year			2010
Income Tax Expense (Benefit)	$ 4,903,000	$ 4,634,000	$ 8,789,000	$ 6,646,000
Effective Income Tax Rate Reconciliation, Percent	36.30%	37.00%	36.20%	37.00%
Deferred Tax Assets, Valuation Allowance	$ 0		$ 0		$ 0